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CHAPTFRI 
AIMS OF THE STUDY 
In the period 1976-1980, in the Camsius-Wilhclmina Hospital, Nijmegen, a retro-
spective study was made of the value of cervical mediastinoscopy in the pre-operative 
evaluation of the operabihty of patients with lung carcinoma. In this study significantly 
more mediastinal lymph node metastases were found in carcinomas spreading from 
the right lung than in those spreading from the left lung, especially in those spreading 
from the left upper lobe This finding is confirmed in the literature. Surgical treatment 
of lung carcinoma with mediastinal lymph node metastasis is still controversial To 
get an insight into this controversy, a study was made of the literature describing the 
results of surgical treatment for lung carcinoma with mediastinal lymph node metasta-
sis Special attention will be paid to the differences in survival rates of patients with 
intranodal or pennodal growth of the mediastinal lymph node metastasis after resec-
tional surgery. The ultimate aim of the study was to determine the value of cervical 
and parasternal mediastinoscopy The central question of the issue is whether using 
cervical mediastinoscopy in the pre-operative evaluation of the operabihty of patients 
with lung carcinoma would contribute to the selection of patients in whom the opera-
tion would be justified The answer to this question will be based on the results of 
surgical treatment for lung carcinoma with mediastinal lymph node metastasis 
(whether or not established at previous cervical mediastinoscopy), published in the 
literature or obtained from our own patient material It should be remarked that here 
we are not concerned with indications for palliative resection for lung carcinoma, but 
with the selection of patients who can be considered amenable to potentially curative 
resection In order to make it possible to compare the results of the various authors, 
the concept of surgical salvage will be used according to Paulson (1971) This concept 
can be defined as an arithmetical formula- surgical salvage = % 5-year survival -
% operative mortality at resection - % operative mortality at only explorative thoraco-
tomy 
A correct interpretation of the results of cervical mediastinoscopy requires detailed 
knowledge of the anatomy of the mediastinum and the lymphatic drainage of the 
lungs The lymphatic drainage of the left upper lobe passes mainly via the pen-aortic 
lymph nodes (the left anterior mediastinal lymph node chain), which are inaccessible 
at cervical mediastinoscopy This accounts for the fact that at cervical mediastinoscopy 
more lymph node metastases were identified in carcinomas spreading from the right 
lung than in those spreading from the left lung, especially from the left upper lobe. 
These pen-aortic lymph nodes can be reached and examined via the left parasternal 
approach of mediastinoscopy. The technique of parasternal mediastinoscopy will be 
discussed The question will be examined in which way parasternal mediastinoscopy 
could improve the selection of patients in the pre-operative evaluation of the operabi-
hty of patients with lung carcinoma spreading from the left lung, especially from the 
left upper lobe, who are considered amenable to potentially curative resection. 
Therefore from 1981-1984 we conducted a prospective study of patients with left-
1 
sided lung carcinomas in order to assess the opcrability In this scries both cervical 
and parasternal mediastinoscopy were performed to determine the presence or absence 
of mediastinal lymph node metastasis 
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CHAPTER II 
TOPOGRAPHY FORPARASTERNAL 
MEDIASTINOSCOPY 
11.1 Introduction 
The mediastinum contains a number of vital organs which have a close and complex 
interrelationship. The surgeon who performs cervical or parasternal exploration of 
the mediastinum may be assumed to know the topographical location of all structures 
which are found in this region. The anatomy relevant to cervical mediastinoscopy 
is extensively described by Akovbiantz, 1977. Adequate knowledge of the anatomical 
structures involved is a precondition for parasternal mediastinoscopy as well. 
11.2 The borders of the mediastinum 
Pernkopf, 1943, describes the mediastinum as the central part of the thorax separat­
ing the two pleural sacs. The anterior border is constituted by the sternum and the 
ribs, the posterior border by the vertebral column. The diaphragm constitutes the 
Fig. 2-1. Subdivision of the mediastinum into two 
compartments 
A. Anterior mediastinum 
В Posterior mediastinum. 
clavicl 
trachea 
Fig 2-2 Subdivision of the mediastinum into four 
compartments 
A. Superior mediastinum 
B. Anterior mediastinum 
С Middle mediastinum. 
D. Posterior mediastinum. 
(According to Flavio di Prêta. 1979) 
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caudal border Cranially, the mediastinum communicates with the soft tissue of the 
neck by the superior thoracic aperture. The vital organs in the mediastinum are embed-
ded in a fine texture of loose connective tissue 
Tondury, 1965, and Kubik, 1968, divide the mediastinum into two separate com-
partments the anterior and the posterior mediastinum. The imaginary plane of section 
between them passes in a frontal plane through the back of the trachea and the main 
bronchi and the dorsal pericardial sac Flavio di Prêta, 1979, modifies this plane of 
section in the superior mediastinum and situates it in front of the trachea and the 
main bronchi (fig 2-1 ) Also, he divides the mediastinum into a superior and an inferior 
part (fig 2-2) For the surgeon, figure 2-2 represents the most useful anatomical divi-
sion of the mediastinum into different compartments, since it visuali7es best the recip-
rocal position of the organs This is of practical importance for the topographical 
identification of the structures that permit the introduction of instruments. The poste-
rior and anterior compartments are in the upper portion, divided by the pretracheal 
fascia This fascia is a constant connective tissue structure which represents a useful 
anatomical point of orientation in cervical mediastinoscopy 
The field of investigation for parasternal mediastinoscopy is the supracardiac part, 
in particular the aortic arch According to Kubik the supracardiac part contains, from 
ventral to dorsal, the thymus (or the remnant of it), the brachiocephalic veins, the 
superior vena cava, the aortic arch, the pulmonary trunk, the trachea and the main 
bronchi, the phrenic and vagus nerves and the lymph vessels that accompany the large 
vessels. 
II.3 Topography of mediastinal organs relevant to left-sided parasternal mediastino-
scopy. 
In this context the following organs are important the aortic arch, pulmonary ar-
tery, vagus nerve, phrenic nerve and mediastinal pleura Fig 2-3 and fig 2-4 
¡13 I A or/и arch 
The ascending aorta arises from the left ventricle, medial to the superior vena cava, 
and dorsally slightly to the right of the pulmonary trunk The course of the ascending 
aorta is entirely intrapencardial In its right ventral course, the ascending aorta con­
tinues into the aortic arch at the level of the 2nd sternocostal articulation. 
Sessay, 1976, reports that the pericardial aortic recess is shorter in most women. 
The aortic arch is cxtrapencardially situated and it curves from ventral right to dorsal 
left through the superior mediastinum (supracardiac part) In a sagittal plane the aorta 
runs initially in front of the trachea, then arches over the left main bronchus and 
to the left of the trachea it continues into the descending aorta at the level of the 
lower edge of the fourth thoracic vertebra The descending aorta lies further to the 
left, paravertebrally The large vessels to the upper body arise from the aortic arch, 
at the convex side of it They are, from right to left. 
1 brachiocephalic trunk (innominate artery) 
2 left common carotid artery 
3 left subclavian artery. 
4 
Fig. 2-3 Topography of mediastinal structures rel-
evant to mediastinoscopy. 
1 
2 
3 
4 
5 
6 
1 
2. 
3 
4 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
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Oesophagus 
Left recurrent nerve. 
Left vagus nerve 
Left common carotid artery. 
Left subclavian artery. 
Aortic arch 
Oesophageal nervous plexus. 
Right recurrent nerve. 
Right vagus nerve 
Right common carotid artery 
Right subclavian artery. 
Brachiocephalic trunk. 
Azygos vein. 
In fact, these large vessels lie behind, rather than beside, each other, because the 
aortic arch curves in a virtually sagittal plane. 
The aortic arch has many anatomical variations, anomalies and malformations, 
of which only the large ones are important for parasternal mediastinoscopy. Shuford, 
1974, gives a lucid synopsis of possible malformations, with emphasis on the angio-
graphic features. The most common malformations are dextroversion and a double 
aortic arch, the latter involving the ascending aorta giving off two branches to the 
right of the trachea which subsequently encircle the oesophagus and the trachea: the 
ventral branch has a pretracheal, the dorsal, a retro-oesophageal course. They anasto-
Fig. 2-4. Pulmonary trunk and arteries. 
1. Left main bronchus. 
2. Left pulmonary artery. 
3. Pulmonary trunk 
4. Right mam bronchus. 
5. Right pulmonary artery. 
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mose to the left of the trachea and the oesophagus, and continue into the descending 
aorta 
II3 2 Pulmonar\ artery 
The pulmonary trunk arises from the right ventricle and initially runs to the left, 
intrapericardially, ventral to the ascending aorta In a horizontal plane it lies slightly 
caudal and ventral to the tracheal bifurcation and there it gives off the left pulmonary 
artery 
The left pulmonary artery crosses the left main bronchus in front, caudovcntrally 
situated in relation to the aortic arch, and reaches the left lung via its hilus The obliter-
ated Botallo's duct remains as the ligamentum artenosum, running between the cranial 
side of the bifurcation of the pulmonary trunk and the lower side of the aortic arch, 
Pernkopf, 1943 and Sessay, 1976 
Anomalies of pulmonary arteries are very rare The left pulmonary artery, however, 
may sporadically cross the left main bronchus and pass behind the trachea to make 
a convex curve to the right, to curve to the left and to reach the left hilus 
¡1.3.3 Left vagus nerve 
After entering the mediastinum, the left vagus nerve passes caudally between the 
left common carotid artery and the left subclavian artery The aortic arch is crossed 
in front, and there the left recurrent nerve branches off passing under the aortic arch 
and returning dorsally and cramally to reach the cervical region again via a sulcus 
between the trachea and the oesophagus Below the aortic arch the left vagus nerve 
passes dorsally, giving off branches to the pulmonary plexus. In its further course 
the left vagus nerve lies across the left and ventral side of the oesophagus, which is 
partially innervated via the oesophageal plexus 
II3 4 Left phrenic nerve 
The left phrenic nerve lies on the left anterior scalene muscle and in the mediastinum 
it closely commumcdtes with the mediastinal pleura and the left subclavian artery 
Caudally, it comes into contact with the left pleurapcncardial membrane 
During high parasternal exploration (ι e inspection along the cranial side of the 
aortic arch) care must be taken not to damage the left phrenic nerve at this site. 
¡1.3.5 Mediastinal pleura 
The mediastinal pleura constitutes the lateral border of the mediastinum and on 
the right side it covers the superior vena cava, the trachea, the laterotracheal lymph 
nodes, the oesophagus, the vagus nerve and the phrenic nerve On the left side it covers 
the aortic arch, the laterotracheal lymph nodes, the left common carotid artery and 
the subclavian artery, as well as the left vagus nerve and the left phrenic nerve 
6 
11.4 REFERENCES 
1 AkovbiantzA Die Mediastinoskopie Verlag Hans Iluber. Bern, 1977 
2 Flavio di Prêta II substrato anatomico della mcdiastinoscopia Arch Ital Anat e Embnol VolLXXXIV-
Fas(.3. 1979 
3 Haffcrl A Lehrbuch der topographischen Anatomie 3 Auíl Seile 356-357, Springer, Berlin, Heidelberg, 
New York, 1969 
4 Kubik I Farbphoto-Allas der topografischen Anatomie, Band III, Thorax Thieme, Stuttgart, 1968 
5 Kubik I, Tumbol Τ Über die Abflussfolge der regionaren Lymphknoten der Lunge des Hundes Acta 
Anat 33 116,1958 
6 Kubik I. Vukelety T, Balint J Die Lokalisation der Lungcnscgmcntc in den regionalen Lymphknoten 
Anat An? 104 104, 1957 
7 Pernkopf E Topografische Anatomie des Menschen Lehrbuch und Atlas der regionar-stratigra-
phischen Praparalion, Urban und Schwarzcnberg, Berlin, Wien, 1943 
8 Sessay A, Dietzel К Untersuchungen zur Pcricardgefahrdung bei der Mcdiastinoskopic Ζ Erkrank 
Atm -Org 145 395, 1976 
9 Shuford WH, Sijbers RG The aortic arch and its malformations Thomas, Springfield 1974 
10 TonduryG Angewandte und topographische Anatomie Thicmc, Stuttgart, 1965 
CHAPTFR III 
INTRATHORACIC LYMPHATIC DRAINAGE 
ULI Introduction 
At the turn of the century the lymphatic drainage of the lungs was still poorly under-
stood. Sukiennikow was one of the first to bring some system into the arrangement 
of the lymph nodes of both lungs, introducing in 1903 a useful and practical nomencla-
ture 
The anatomy of the bronchial tree, the trachea and the main bronchi forms the 
basis for his topographical description of tracheobronchial and pulmonary lymphatic 
drainage These lymph nodes receive primarily lymph from the intrathoracic bronchial 
airways The bronchial tree and the trachea are anatomically recognizable structures, 
via which, according to Sukiennikow, lymphatic drainage passes We owe to him such 
terms as right and left tracheobronchial nodes and subcannal nodes, which are still 
in use According to Sukiennikow, the intrapulmonary and hilar lymph nodes (bron-
chopulmonary nodes) arc in variably situated at points where bronchial branches bifur-
cate 
Engel, 1926, on the other hand claims, after studying infants' lungs, that the lym-
phatics do not run parallel to the bronchial tree, but parallel to the vascular system, 
in particular, parallel to the pulmonary artery 
Beil/ke, 1923, 1925, 1926, supports this view Engel points to the existence of aortic 
nodes and the node of Botallo, which is regarded as the origin of the left tracheobron-
chial lymph node chain 
Steinerl's, 1928, description of the lymph drainage of the lung is based on microscop-
ical examination of foetal lungs, which invariably shows that lymphatic tissue is to 
be found between the bronchus and the attendant vessels in the wide-mazed mesoblast 
tissue Steinen points out that both upper lobes often drain directly to the correspond-
ing tracheobronchial lymph node chain (aortic nodes and node of Botallo). The lower 
lobes of the lungs drain mainly to the hilar and bifurcation lymph nodes 
The most comprehensive research on lymphatic drainage of the lungs has been done 
by Rouvière, 1927, 1928, 1929, 1932, whose topographical description of both the 
visceral and the parietal lymphatics remains a classic and is accepted by virtually all 
authors His findings are based on post-mortem studies taken from more than 200 
lungs of foetuses, newborn infants and young adults. In his view there are 3 main 
drainage regions in both the right and the left lung. Fig 3-1 
His pupil Cordier, 1958, tried to refine the system set up by Rouvière, by examining 
the lymph drainage pathways of the isolated lung segments separately He examined 
a total of 90 segments, coming from both lungs. He established which segments of 
the left lung also drain to the left anterior mediastinal lymph node chain They are 
the apical, dorsal and ventral segments of the upper lobe, and the cranial and caudal 
segments of the lingula. Munka, 1963, Nohl, 1962,1972,1983, Sarrazin, 1974, support 
these findings 
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big 3-1 Lymphatic drainage of the left lung, ac-
cording to Rouviere, 1932 
1 Superior part 
2 Intermediate part 
3 Inferior part 
Weinberg, 1951, has traced all groups of regional lymph nodes described by Rou-
viere, in his pre-operatively dyed lymph nodes. He found no natural connection be-
tween the right paratracheal lymph nodes and the lymph nodes in the left antero-
supenor mediastinum. 
Borrie, 1952, emphasized the common lymph drainage of the lobes adjacent to each 
other in the left as well as the right lung. These drain eventually to Borne's lymphatic 
sump node, as modified by Nohl. 
Sarrazin points to the importance of lymphatic drainage to the abdomen. 
In the early 1950's tuberculosis in particular played a large part in the research 
of the pulmonary lymphatic drainage. In the mid and late ^SO's a lot of research 
took place in the study of lymphatic metastasis. Routine cervical exploration of the 
mediastinum in the pre-operative determination of the opcrability of the lung carcino-
ma (according to the method developed by Carlens, 1959, cervical mediastinoscopy) 
has increased our knowledge of mediastinal lymphatic drainage. 
The parietal lymph node chains cannot be reached by mediastinoscopy. For a de-
scription of them, sec Rouviere: 'Les lymphatiques de l'homme' (1932). They fall into 
three categories: antero-parietal, postero-parietal and diaphragmai position. Rouviere 
divides the visceral lymph node chains into 6 main groups: 
1 pulmonary lymph nodes 
2 anterior mediastinal lymph nodes 
3 posterior mediastinal lymph nodes 
4 tracheobronchial lymph nodes 
5 cannai lymph nodes 
6 paratracheal lymph nodes 
9 
Group 1 comprises all lymph nodes that are always removed when a pneumonec-
tomy is performed (an extrapencardial resection, without removal of the mediastinal 
lymph nodes) 
Groups 2-6 comprise all mediastinal lymph node chains 
III.2 Pulmonary lymph nodes 
III 2 1 Pulmonary lymph nodes 
The pulmonary lymph nodes are subdivided into intrapulmonary and bronchopul-
monary lymph nodes. In turn, the latter can be subdivided into hilar and interlobar 
nodes 
The intrapulmonary lymph nodes communicate either with a junction of segmental 
or small bronchi, or with the bifurcation of branches of the pulmonary arteries They 
are rarely found near the pleura The bronchopulmonary lymph nodes are situated 
either along the lower parts of the main bronchus - the hilar lymph nodes - or in 
the angle formed by the bifurcation of the lobar bronchi the interlobar nodes. The 
latter are accordingly found in the interlobar fissures These interlobar nodes consti-
tute the 'lymphatic sump', first described by Borne and known as Borne's lymphatic 
sump. All adjacent lobes of the lung drain to this region 
Generally speaking, where lung drainage is concerned, Rouvièrc's concept of a lung 
divided into an upper, middle and lower region still holds This concept has been com-
plemented by Cordier in common with Sarrazin's research of the lymphatic drainage 
from the lung segments, and Borne's finding (later modified by Nohl) of a constant 
lymphatic sump which can be affected by metastatic lymph spread arising from tu-
mours of the upper lobe 
III 2 2 Left lung. Fig. 3-2 and fig 3-3 
Upper lobe-
1 Apical segment Deep lymphatics drain to the paratracheal and bifurcation lymph 
nodes Superficial lymphatics drain to the lymph node chains in the antero-superior 
mediastinum. 
2 The anterior segment drains to the paratracheal and bifurcation lymph nodes and 
to the antero-superior mediastinal lymph node chains 
3 The posterior segment drains to the paratracheal and the anterior mediastinal lymph 
node chains 
4 The lingular segments drain to the antero-superior mediastinum where superficial 
lymphatics are concerned Deep lymphatics drain to Borne's lymphatic sump node 
and then on to the bifurcation nodes and from there to the paratracheal lymph 
node chains 
Lower lobe-
1 The apical segment drains to the paratracheal and bifurcation lymph nodes 
2 The basal segments drain mainly to the bifurcation lymph nodes To a lesser extent 
10 
Fig 3-2. Posterior view of lymphatic drainage of 
the left lung 
Left paratracheal lymph nodes 
Left antcnor mediastinal lymph nodes. 
Left superior tracheobronchial lymph nodes. 
Left inferior tracheobronchial lymph nodes, bi-
furcation lymph nodes. 
Interlobar lymph nodes, lymphatic sump nodes 
they drain to the left paratracheal lymph node chain. Seldom do they drain to the 
inferior pulmonary ligament and the subdiaphragmai aortic lymph nodes. 
In summary, the superior region of the left lung drains to the paratracheal lymph 
node chain and to the anterior mediastinal lymph node chain. The middle region, 
comprising the lower part of the upper lobe and the upper part of the lower lobe, 
drains to the paratracheal, bifurcation and the anterior mediastinal lymph node chains. 
The inferior region drains mainly to the bifurcation lymph nodes. It seldom drains 
to the inferior pulmonary ligament and the paratracheal lymph node chain. A left-right 
cross-over of the lymphatic drainage takes place via the bifurcation nodes. 
III.2.3 Borrie 's left lymphatic sump, modified according to Nohl. Fig. 3-4. 
The group of lymph nodes placed in the main fissure between the upper and lower 
lobes constitute Borric's left lymphatic sump. Nohl claims that some lymph nodes 
are invariably placed in the lymphatic sump. 
11 
Fig 3-3 Anlenorviewoflymphaticdrainageofthe 
left lung 
1 Anterior mediastinal lymph node chain 
2 Inferior tracheobronchial lymph nodes 
3 Interlobar lymph nodes, lymphatic sump nodes 
big 3-4 Postero-lateral view of the left lymphatic 
sump according to Borne, modified by Nohl 
1 Lymph nodes situated along the left pulmonary 
artery, the origin of the left anterior mediastinal 
lymph node chain 
2 Interlobar lymph nodes, the origin of the left par-
atracheal lymph node chain 
3 Lymph nodes situated along the lelt pulmonary 
vein, draining to the bifurcation Ijmph nodes 
12 
a a lymph node placed in the bifurcation of the bronchus between the upper and 
lower lobes 
b a group of lymph nodes on the stem of the left pulmonary artery and in the angles 
of its branches 
с a lymph node postero-superior to the left pulmonary artery under the aortic arch 
and lateral to the left main bronchus 
d a lymph node placed above the pulmonary vein communicating with the tracheo­
bronchial lymph nodes further up 
HI 2 4 Right lung 
Upper lobe 
1 The apical segment drains to the azygos lymph nodes and the right paratrachcal 
lymph node chain 
2 The anterior segment drains to the paratrachcal, the bifurcation and sometimes 
to the right anterior mediastinal lymph node chain. 
3 The posterior segment drains to the bifurcation and the right paratrachcal lymph 
node chains 
Middle lobe 
Both segments of the middle lobe drain to the paratrachcal and bifurcation lymph 
nodes, either directly or by way of the lymphatic sump nodes. 
Lower lobe 
The apical segment drains to the bifurcation lymph nodes, to the paratrachcal lymph 
node chain and to the right inferior pulmonary ligament 
The basal segments drain to the bifurcation and interlobar lymph node chains as 
well as to the right inferior pulmonary ligament 
In summary, the superior region of the right lung drains to the paratrachcal lymph 
node chain The middle region (comprising a part of the anterior segment of the upper 
lobe and middle lobe, and a pari of the apical segment of the lower lobe) drains to 
the paratrachcal lymph nodes, the bifurcation lymph nodes, and sometimes to the 
right anterior mediastinal lymph nodes The lower region drains to the bifurcation 
and interlobar lymph nodes and to those placed in the inferior pulmonary ligament 
In both lungs the lymph nodes in the inferior pulmonary ligament communicate 
with the intrathoracic retro-oesophageal lymph nodes, and with the para-aortic lymph 
nodes in the abdomen. The nght-lcft cross-over of lymphatic drainage is described 
in the literature, too (Kubik 1957, Maassen 1965, Maasscn 1971, Palva 1973, Sarrazin 
1974). 
Weinberg, 1951, Greschuchna, 1971, Nohl-Oser, 1971, Lacquet, 1976, all confirm 
the contralateral left-right cross-over and its right-left counterpart. 
III.2.5 Воте'ч right lymphatic sump, modified according to Nohl 
The lymph nodes in this region arc centred near the intermedial bronchus The re­
gion covers the area between the right upper lobe above the middle lobe and the bron-
13 
Fig 3-5 Antenor view of lymphatic drainage of the 
tracheobronchial tree 
1 Left paratrachcal lymph nodes 
2 Left superior tracheobronchial lymph nodes 
3 Inferior tracheobronchial bifurcation lymph 
nodes. 
4. Left inferior tracheobronchial lymph nodes. 
5. Interlobar lymph nodes. 
6. Right paratrachcal lymph nodes 
7 Azygos lymph nodes 
8 Right superior tracheobronchial lymph nodes 
9. Right inferior tracheobronchial lymph nodes. 
chus in the superior segment of the right lower lobe. Nohl invariably finds a lymph 
node in the superior and posterior part of the main fissure between the right upper 
lobar bronchus and the intermedial bronchus. This lymph node communicates with 
the subcarinal lymph nodes. Other lymph nodes in this area are found close to the 
interlobar part of the right pulmonary artery or at the bifurcation of its branches. 
They communicate with more anteriorly placed lymph nodes between the upper lobar 
branches of the superior pulmonary vein and with the bronchus in the anterior segment 
of the upper lobe (by compressing this segment they may cause bronchiectasis). Cran-
ially they communicate with the azygos lymph node (placed under the vena azygos). 
Similarly the middle lobar bronchus is surrounded by lymph nodes. All three lobes 
of the right lung drain into the lymphatic sump. The right upper lobe never drains 
lymph below the line indicated in the diagram (modification of the lymphatic sump 
according to Nohl). 
III.3 Mediastinal lymph nodes 
III.3.1 Mediastinal lymphatic nodes (groups 2-6). Fig. 3-5 and fig. 3-6. 
of anterior mediastinal Fig 3-6. Anterior view 
lymph nodes (black) 
1 Left paralracheal lymph nodes 
2. Antcro-intermediate mediastinal lymph node 
chain. 
3 Right anterior mediastinal lymph nodes. 
4 Left anterior mediastinal lymph nodes 
5 Botallo's lymph node, ligamentum artcriosum. 
6. Azygos lymph node 
7. Inferior tracheobronchial bifurcation lymph 
nodes 
8. Left lobar, hilar lymph nodes. 
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The mediastinal lymph nodes are subdivided into 5 groups 
2 Anterior mediastinal lymph nodes 
3 Posterior mediastinal lymph nodes 
4 Tracheobronchial lymph nodes 
5 Cannai lymph nodes 
6 Paratracheal lymph nodes 
III 3 2 Anterior mediastinal lymph nodes (also known as prevascular lymph nodes) 
The lymph nodes he in the superior mediastinum in front of the large vessels that 
leave or enter the heart. 
There are two vertical lymph node chains and one horizontal lymph node chain 
(transversal), which connects the left and the right vertical lymph node chains. 
The right vertical lymph node chain is placed in front of the large veins, the superior 
vena cava and the right brachiocephalic trunk The lymph nodes are usually placed 
along the phrenic nerve This lymph node chain is part of an ascending lymphatic 
drainage pathway of the right anterior mediastinum. This ascending pathway is of 
minor importance for bronchus carcinoma. On the other hand, the left ascending path-
way, which includes the lymph nodes in the left antcro-supenor mediastinum, is very 
important for the drainage of lymph coming from the left lung, in particular coming 
from the upper lobe This lymph node chain, which is prearlenally placed and is often 
termed preaortocarotidial, originates in the lymph node of Botallo's ligament. This 
node is mostly transversally placed, close to the left pulmonary artery, right in front 
of the arterial channel. This lymph node chain ascends between the phrenic nerve 
and the vagus nerve The lymph it transports comes from the pleura, the pericardium, 
the thymus and above all from the left lung Its lymph drains into the thoracic duct 
or directly into the left subclavian vein This is the most important lymph node chain 
for a parasternal mediastinal examination 
The transversal lymph node chain, placed along the left brachiocephalic trunk anas-
tomoses the two vertical lymph node chains, with each otherand with the right paratra-
cheal lymph node chain (Rouvière, 1932) Its significance is small, since it transports 
lymph from the thyroid gland, the thymus and the trachea 
/ / / 3 3 Posterior mediastinal lymph nodes 
The position of most of these lymph nodes is para-oesophageal, interaorto-oesopha-
geal and retro-oesophageal They transport lymph from the diaphragm, the diaphrag-
mai part of the pleura, the oesophagus and a part of the lower lobes of both lungs 
The inferior pulmonary ligament lymph node groups (placed below the level of the 
inferior pulmonary vein) belong to this group and anastomose with para-aortic nodes 
below the diaphragm (Nohl, 1983). Neither cervical nor parasternal mediastinoscopy 
can reach these nodes. 
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/// 3 4 Τι acheobroni fual hmph nodes 
These are the object of cervical mediastinoscopy They communicate with the left 
and right hilar lymph node groups The superior tracheobronchial lymph nodes are 
placed to the left and to the right of the main bronchus These lie outside the pretracheal 
fascia In the left lung they can anastomose with nodes of the antcro-supenor medias­
tinum In the right lung the superior tracheobronchial lymph nodes are placed near 
the vena azygos arch and above the level of the right pulmonary artery. 
Brock, 1955, describes lymph nodes connecting the inferior and superior tracheo­
bronchial lymph nodes, placed in front of the lower part of the trachea. 
Ill 3 5 Cannai lymph nodes 
These are placed near the bifurcation of the trachea into left and right main bron­
chus, and are divided into subcarinal, inferior tracheobronchial and deep bifurcation 
lymph nodes (in fact para-ocsophageal lymph nodes). In order to reach these during 
mediastinoscopy, the pretracheal fascia has to be opened 
HI 3 6 Para trac heal lymph nodes 
These are placed higher up in the superior mediastinum, anterolaterally to the right 
and the left of the trachea under the innominate artery, covered laterally by the superi­
or vena cava on the right side The lymph nodes to the right of the trachea are more 
numerous and larger than those to the left They form the connection between the 
deep cervical lymph nodes situated on the anterior scalene muscle under the omohyoid 
muscle, known as the scalene node, and the superior tracheobronchial lymph nodes. 
Sarrazin (1974) confirms Cordier's findings which show that there is no direct con­
nection between the left paralracheal lymph node chain and the lymphatics of the 
right lung The left paratracheal lymph node chain anastomoses with the left antcro-
supenor mediastinal lymph node chain and with the paratracheal lymph node chain 
on the right side 
III.4 REbiRKNCES 
1 Akovbianl/A Die Mcdiaslinoskopic Hans Huber. Bern, 1977 
2 Beit/ke HHW Atmungsorgane In AscholTs Palhologische Anatomie Bd II S 290 Jena fischcr, 
192"! 
3 Bcit/ke HHW Ubcr lymphogene Slaubvcrschleppung Virchows Arch f pathol Anat u Physiol 254, 
1925 
4 Beitzkc HHW Die pathologisch-anatomischen Unterlagen fur die Diagnose 'Hilusdrusenluberkulosc' 
Aus Blumel(Ed) Handbuch der Tuberkulosefürsorge Lehmann. München. 1926 
5 BorneJ Primary carcinoma of the bronchus Ann R Coll Surg Engl 10 165. 1952 
6 Brock RC, Whytchcad LL Radical pneumonectomy for bronchial carcinoma Brit J Surg 41 8, 1955 
7 Carlcns E Mediastinoscopy A method of inspection and tissue biopsy in the superior mediastinum 
Dis Chest 36 343, 1959 
8 Cordier G. Papamiltiades M, Cedard С Les lymphatiques des bronches et des segments pulmonaires 
Bronches 8 8. 1958 
9 Fngcl SU Die Topographie der bronchialen Lymphknoten und ihre praparatonsche Darstellung Bcitr 
KlinTuberk64 468, 1926 
16 
10 Grcschuchna D, Maassen W New observations of lymphatic spread of bronchogenic carcinoma In 
Jepsen O, Sorenscn MR (Eds) Mediastinoscopy. University Press. Odcnsc, 1971 
11 Grcschuchna D, Maassen W Die lymphogcnc Absiedlungswege des Bronchialkar7inoms Thiemc, 
Stuttgart 1971 
12 Kubik I Viskelety T, Bahnt J Die Lokalisation der I ungensegmente in den regionalen Lymphknoten 
Anat An? 104 104. 1957 
13 Lacquet LK, Mertens A Kleef J van, Jongenus CM Mediastinoscopic en longcarunoom Ervaring 
met600mediastinoscopiecn Acta Chir Belg 75 187 1976 
14 Maassen W, Kirsch M Specht G Thummler M, von Windheim К Mediastinoscopic et cancer bron­
chique Bronches 15,492, 1965 
15 Maassen W, Grcschuchna D Allgemeine und spc7iclle Ergebnisse der Mcdiastinoskopie unter beson­
derer Berücksichtigung des Bronchialkar/inoms Thoraxchir 19 289 1971 
16 Munka W Das Lymphgcfass-System der Lungen vom Standpunkt ihrer Segmentstruktur Biol Prace 
Bratislava 1964 Ref ZblTuberk Forschung 94 Π1 1963 
17 Nohl HC The spread of carcinoma of the bronchus Lloyd-Luke London, 1962 
18 Nohl HC An investigation of the anatomy of the lymphatic drainage of the lungs Ann R Coll Surg 
Engl 51 157, 1972 
19 Nohl-Oser HC The lymphatic spread of carcinoma of the bronchus In Mediastinoscopy Jepsen O, 
Serensen HR (Eds) University Press Odensc 1971 
20 Nohl-Oser HC Lymphatics of the lung In Shields TW (Ed) General Thoracic Surgery, 2 ed , Lea 
and Fcbigcr, Philadelphia 1983, p72-81 
21 PalvaT, KarjaJ PalvaA Mediastinoscopic observations of metastatic spread in pulmonary carcinoma 
Acta Otolaryng 73 443 1973 
22 Rouviere H Systématisation el topographie des ganglions et des vaisseaux lymphatiques sous-slerno-
mastoidiens et sus-claviculaires Société Analomiquc de Pans, Seance avril 1927 
23 Rouvierc H Sur les connections des lymphatiques du lobe inferieur du poumon gauche avec les ganglions 
paratracheaux droits et sus-claviculaires droits Ann Anat path 5, 1928 
24 Rouviere H Les vaisseaux lymphatiques des poumons et les ganglions viscéraux intrathoraciques Ann 
Anal path 6 113, 1929 
25 Rouvicrc H I es lymphatiques de l'homme Masson, Pans 1932 
26 Sarrazin R, DyonJI Les lymphatiques du poumon Bulletin Assoc Anat 58 1043, 1974 
27 Steinen R Untersuchungen über das Lymphsystem der L unge Beitrage zur Klinik der Tuberkulose 
68 497 1928 
28 Sukiennikow WL Topographische Anatomie der bronchialen und trachcalcn I ymphdrusen Berliner 
KlinWschr 14 316, 1903 
29 Weinberg JA Identification of regional lymph nodes in the treatment of bronchogenic carcinoma J 
ThoracSurg22 517, 1951 
17 
CHAPTER IV 
STAGE AND STAGING. THE TNM SYSTEM 
IV. 1 Introduction 
In general, the prognosis of bronchus carcinoma is poor The 5-year survival rate 
in randomly selected patient series varies between 5 and 10%, and has remained un­
changed in the past 30 years, despite the heroic efforts which have been made to devel­
op effective treatment as mentioned by Boucot, 1959, Burford, 1959, Spjut, 1961, Lars-
son, 1973, Ashor, 1975, Mittman, 1977, Nohl, 1980, Adler 1983 
The resectabihty of the carcinoma depends on the location of the primary tumour 
and on any tumour extension into adjacent, in particular mediastinal, structures 
The operabihty depends on the presence of metastatic lymph nodes in the mediastin­
um and on such factors as the patient's general condition, lung function and any con­
comitant disease(s). 
The assessment of the location and eventual spread of the tumour to the lymph 
glands and'or adjacent tissues is called 'staging' and is essential in determining which 
procedure is to be followed in treating the patient 
Salzer, 1951, was one of the first to develop a system of staging which is still in 
use today (Nohl, 1980) The American Joint Committee on Cancer (AJC) recommends 
the TNM classification, a staging system which is now internationally accepted This 
system aims to ensure the comparability of therapeutic results obtained from different 
studies Denoix first developed the basic principles of the TNM system for the classifi­
cation of malignant tumours in the period 1943-1952 (Noordijk, 1983) As early as 
1973 Larsson, after carefully analyzing his patient material, proposed a highly accurate 
modification of the TNM system, but the complexity of this system has hindered its 
introduction 
The TNM system is a simple and accurate classification system for the extent of 
the disease. It is based on 3 categories 
Τ the extent of the primary tumour 
N regional lymph node involvement 
M distant metastasis 
The present study follows the classification (and numbers) as proposed by the AJC, 
1983 There is a distinction between staging and stage-grouping 'Staging' refers to 
the assessment of the apparent extent of the disease at the patient's initial examination, 
whereas 'stage-grouping' refers to the formation of groups of TNM variables which 
can be used as a standard or criterion In 1983 the American Thoracic Society (ATS) 
proposed a refined version of the staging system of lymph node metastasis It is not 
used in this study 
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IV.2 Stage-grouping 
The TNM system forms the basis for the stage-grouping in bronchus carcinoma 
Here the TNM variables are presented as defined by the AJC, 1983. 
Definitions of Τ, N and M categories for carcinoma of the lung 
Primary Tumour (T) 
TX Tumour proved by the presence of malignant cells in bronchopulmonary secre­
tions but not visualized roentgenographically or bronchoscopically, or any tu­
mour that cannot be assessed as in the retreatment staging (For retrcatment 
staging, see IV 4) 
TO No evidence of primary tumour 
TIS Carcinoma in situ 
Tl A tumour that is 3 0 cm or less m greatest diameter, surrounded by lung or 
visceral pleura, and without evidence of invasion proximal to a lobar bronchus 
at bronchoscopy 
T2 A tumour more than 3 0 cm in greatest diameter, or a tumour of any size that 
either invades the visceral pleura or has associated atelectasis or obstructive 
pneumonitis extending to the hilar region At bronchoscopy, the proximal extent 
of demonstrable tumour must be within a lobar bronchus or at least 2.0 cm 
distal to the carina Any associated atelectasis or obstructive pneumonitis must 
involve less than an entire lung, and there must be no pleural effusion 
T3 A tumour of any size with direct extension into an adjacent structure such as 
the parietal pleura or chest wall, the diaphragm or the mediastinum and its con­
tents, or a tumour demonstrable bronchoscopically to involve a main bronchus 
less than 2 0 cm distal to the carina, or any tumour associated with atelectasis 
or obstructive pneumonitis of an entire lung or pleural effusion 
Nodal Involvement (N). 
NX Minimum requirements to assess the regional nodes cannot be met 
NO No evidence of involvement of regional lymph nodes. 
N1 Metastasis to lymph nodes in the peribronchial or the ipsilateral hilar region, 
or both, including direct extension 
N2 Metastasis to lymph nodes in the mediastinum 
Distant Metastasis (M) 
MX Minimum requirements to assess the presence of distant metastasis cannot be 
met. 
MO No evidence of distant metastasis. 
M1 Distant metastasis present Specify site. 
Each case must be assigned the highest category Τ, N and M, which describes the 
full extent of the disease in that case. These variables can be combined for the stage-
grouping according to the TNM system The combinations have been reduced to three 
groups, each corresponding to a stage with a specific survival curve 
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IV.3 Stage-grouping in carcinoma of the lung 
Occult Stage. 
TX NO MO Λη occult carcinoma with bronchopulmonary secretions containing 
malignant cells but without other evidence of the primary tumour or 
evidence of metastasis to the regional lymph nodes or distant metasta­
sis. 
Stage I 
TIS NO MO Carcinoma in situ. 
Tl NO MO A tumour that can be classified Tl without any metastasis or with 
Tl N1 MO metastasis to the lymph nodes in the peribronchial and/or ipsilateral 
hilar region only, 
T2 NO MO or a tumour that can be classified T2 without any metastasis to nodes 
or distant metastasis. 
Note: TX N1 MO and TO N1 MO are also theoretically possible, but such a clinical 
diagnosis would be difficult if not impossible to make. If such a diagnosis is made, 
it would be included in stage I. 
Stage II 
T2 N1 MO A tumour classified as T2 with metastasis to the lymph nodes in the 
peribronchial and/or ipsilateral hilar region only. 
Stage III 
T3 with any N or M Any tumour more extensive than T2, or any tumour with 
N2 with any Τ or M metastasis to the lymph nodes in the mediastinum, or 
M1 with any Τ or N any tumour with distant metastasis. 
Fig. 4-1. The American Joint Commitlee on Cancer classification oCrcgional lymph nodes, 1983. 
N 2 Nodes 
Supenor Mediastinal Nodes 
I. Highest Mediastinal 
2 Upper Paratracheal 
3. Pre- and Relrotracheal 
4 Lower Paratracheal or tracheobronchial (including Azygos Nodes) 
Aortic Nodes 
5. Subaortic (aortic window) 
6. Para-aortic (ascending aorta or phrenic) 
Inferior Mediastinal Nodes 
7. Subcannai 
8. Paraesophageal (below carina) 
9. Pulmonary Ligament 
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N, Nodes 
10. Hilar 
11. Interlobar 
12. Lobar 
13. Segmental 
In general, stages I and II are considered amenable to surgical treatment with a 
high percentage of 5 or 10-ycar survival, whereas stage III is not In the literature, 
however, the treatment of N2 lung carcinomas is still controversial. (Sec chapter VII 
for a discussion of N2 lung carcinomas that were resected ) 
Fig 4-1 
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IV.4 Stage assessment 
A distinction can be made between 5 forms of staging. 
1 Clinical staging, cTNM, staging at the patient's first presentation. 
2 Surgical staging, sTNM, staging at explorative thoracotomy. 
3 Post-surgical pathological staging, pTNM, staging after examination of resected 
specimens by the pathologist 
4 Retreatment staging, rTNM, staging because of indications that treatment should 
be continued, as in a case of recurrence after resection. 
5 Autopsy staging, aTNM, postmortal staging 
In the following chapters the term TNM should be read aspTNM, ι e staging based 
on histopathological findings Unless otherwise stated, the pre-operative assessment 
of the N status was obtained through cervical, parasternal or combined mediastino­
scopy Carlens, 1982, has shown that only histopathological evidence determines the 
N2 status 
In the period when the present study was conducted, the original N classification 
of lymph node metastasis as presented in chapter IV 2 was used in the Canisius-Wilhel-
mina Hospital, the Radboud Hospital and the Dekkerswald lung centre A drawback 
of this classification is that it does not specify data on intra or perinodal growth nor 
on the exact locations of metastases in mediastinal lymph nodes These will therefore 
be stated separately. 
According to the original classification the visceral pleura constitutes the border 
(recognizable only at thoracotomy) between hilar and lower paratracheal or medias­
tinal metastases (N1 and N2 status respectively) In 1983 the ATS proposed relating 
it to structures which are anatomically recognizable during the various forms of staging 
(fig 4-1) Accordingly, the lower paratracheal or tracheobronchial lymph nodes on 
the right side and the peribronchial lymph nodes on the left side - whose location 
is precisely defined - arc classified into group N1-2 The other mediastinal lymph 
nodes fall under the N2 group. This classification also specifics intra or perinodal 
growth, as well as ipsi, contra or bilateral occurrence (as was proposed by Larsson 
in 1973). 
For an extensive discussion of the TNM variables, see Larsson, 1973, AJC, 1983, 
ATS, 1983 and Noordijk, 1983. 
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CHAPTER V 
THE TECHNIQUE OF PARASTERNAL 
MEDIASTINOSCOPY IN THE 
CANISIUS-WILHELMINA HOSPITAL 
V.l Introduction 
The risks attached to parasternal mediastinoscopy in the evaluation of the operabi-
lity of left-sided bronchus carcinoma, are not unacceptable The procedure takes place 
under general anesthesia and is limited to a small intrathoracic area in which important 
anatomical structures are situated The surgeon should not only be familiar with the 
anatomy of the region, bearing in mind that anatomical variations occur, but with 
the risks of the procedure as well. Pre-operative screening is essential and blood should 
be available if necessary The know-how and the instruments for performing an emer-
gency thoracotomy should be available 
V.2 The instruments 
For parasternal mediastinoscopy one operation set is used. 
1 The instruments necessary to make an entry into the anterior mediastinum and 
to close the incision afterwards 
2 The mediastinoscopy set, as used for the cervical approach for the exploration of 
the superior mediastinum The instruments developed by Cadens are ideal for this 
purpose They comprise. 
- mediastinoscope 
- suction-pipe with diathermic coagulation tip 
- lighting 
- biopsy-dissection forceps 
- Langebeck's retractor 
V.3 Position and anesthesia 
Since parasternal mediastinoscopy is often combined with cervical mediastinoscopy, 
it seems logical to position the patient as for cervical mediastinoscopy This position 
is suitable for parasternal mediastinoscopy 
In addition to the routine anesthetic pre-operative work-up, checks should be made 
for the following prior to a mediastinoscopy (Curling. 1983) 
1 The presence of an impaired cerebral circulation when a history of transient ische-
mic attacks, stroke, or a carotid bruit is present 
2 The adequacy of the airway. 
3 The presence of the pseudo-myasthenia syndrome, secondary to carcinoma 
4 The presence of an ascending aortic aneurysm - laboratory tests should be ordered 
to exclude syphilis 
5 Adequate blood cross-matched and available 
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Endotracheal intubation guarantees undisturbed ventilation during muscle relax-
ation 
V.4 The technique of parasternal mediastinoscopy and the protocol of the biopsy proce-
dure. 
Since mediastinoscopy is an intrathoracic procedure, strict asepsis is applied The 
skin is disinfected and covered with sterile cloths making possible both cervical and 
parasternal mediastinoscopy 
The following successive acts are performed: 
1 vertical left parasternal skin incision overlying the second intercostal space 
2 incision of muscles- pectorahs major muscle and intercostal muscle. 
3 identification of internal mammary artery 
4 identification of mediastinal pleura 
5 digital blunt dissection and palpation of the anterior mediastinum 
6 endoscopic inspection of the anterior mediastinum 
7 identification and biopsy of lymph nodes in the anterior mediastinum. The aortic 
arch serves as a point of orientation 
8 closing of the wound. 
Ad 1 The skin incision, necessary for parasternal mediastinoscopy, is made 1 cm 
away from the lateral edge of the sternum and overlies the second left intercostal space 
It is 2,5-3 cm long After the skin and the subcutaneous tissue have been incised, 
the fascia of the pectorahs major muscle comes into view 
Ad 2 The fascia of the pectorahs major muscle is opened in the same direction as 
the skin incision The pectorahs major muscle is incised also in the same direction 
Small arteries and veins, if any, are hgatcd. Next, the intercostal muscle is opened 
as close to the sternum as possible, to prevent lesions of the internal mammary artery 
Ad3. The internal mammary artery arises from the subclavian artery, lies on the trans-
versus thoracis muscle (a rudimentary muscle), and therefore also in front of the inter-
nal thoracic fascia within the range of the parasternal mediastinoscope It is usually 
accompanied by two veins (internal mammary veins) After identification of the inter-
nal mammary artery, it is to be pushed laterally to prevent lesions during the endosco-
pic examination If the internal mammary artery is lacerated, it should be ligated 
Ad 4 After the internal thoracic fascia has been opened, the mediastinal pleura be-
comes visible If possible, it should be left intact With small swabs the mediastinal 
pleura can be pushed laterally, after which the mediastinum can be visualized. Once 
past the mediastinal pleura, and using the index finger, the mediastinum is opened 
by blunt dissection towards the aortic arch 
Ad 5 Digital dissection is done in the direction of the aortic arch, which passes from 
right ventral to left dorsal at the level of the second intercostal space The tip of the 
index finger should serve as the surgeon's 'eye', and the aortic arch serves as a point 
of orientation for the examination of the anterior mediastinum. If deemed desirable, 
bimanual examination can be done via the cervical and parasternal entrance Enlarged 
and pathological nodes can thus be palpated along the upper edge of the arch, in 
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the aortic window and along the left pulmonary artery as well as along the pericardial 
part of the ascending aorta. Sometimes palpation alone is enough to mobilise fixed 
lymph nodes 
By palpation of the anterior mediastinum the wide-meshed, sparsely-vesseled con­
nective tissue and fatty tissue are pushed to the sides forming a tunnel through which 
the mediastinoscope can be inserted At this stage endoscopy and lymph node biopsy 
are performed In general, this presents no problem. Any form of mediastinal patholo­
gy, e g infections and 'or tumours may give rise to adhesions in the mediastinal connec­
tive tissue, which may make dissection difficult or even impossible. Dissection should 
never be forced If dissection via the 'blind' method is unsuccessful, the adhesion 
should be separated under endoscopic control with the mediastinoscope and the blunt 
suction-pipe or a small swab. Above all, lesions of the vessels and nerves should be 
prevented Once the fingertip has reached the aortic arch, it should continue to keep 
in touch with it, ι e. the arch serves as a point of orientation for the blind exploration. 
The arch is easily recognizable by its shape and pulsation, continually felt cramally. 
After blind dissection with the index finger, the mediastinoscope should easily pene­
trate to the aortic arch 
In case of neoplasia, the connective tissue may feel tough and may make dissection 
difficult 
Acl 6 The mediastinoscope is carefully inserted into the space created by dissection. 
If the mediastinoscope meets any resistance on its way, it should never be forced 
through. If adhesions are encountered, they should be carefully dissected by the dissec­
tion forceps or the suction-pipe, under direct visual control If necessary, digital dissec­
tion is again resorted to Usually, the aortic arch is soon reached, and it is recognizable 
by its shape. Once the aortic arch has been established, one starts looking for the 
left pulmonary artery which is located caudally to the aortic arch. 
Normally, lymph nodes are small, soft, bright grey or flesh-coloured They are often 
described as anthracite-coloured, and therefore (bluish) black, and are often adherent 
to their environment, though rarely fixed to it When lymph node metastases from 
a bronchus carcinoma are present, the nodes are very often enlarged, greyish white, 
hard, misshapen, and are often fixed to their environment In general, however, it 
is incorrect to judge nodes, whether involved or not, on the basis of their macroscopic 
aspect. Histological examination is a precondition for the reliability of parasternal 
mediastinoscopic examination 
Aci 7 The aim of parasternal mediastinoscopy is to collect lymph nodes from the anteri­
or mediastinum for histological examination Histological examination determines 
whether or not the carcinoma has spread to the mediastinum If the identification 
of lymph nodes presents problems, aspiration with a long needle can be performed 
to obviate damaging a vessel This applies especially to anthracotic nodes, since they 
could be mistaken for a vein because of their bluish black colour Sometimes palpable 
pathological lymph nodes can be loosened digitally, since the substance of a lymph 
node feels more solid, whereas a vein is soft, impressible and as such indistinguishable 
from its surroundings Tumour tissue, a more solid substance, cannot be distinguished 
from its surroundings The surface feels hard and rough, the colour is bluish grey. 
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Arteries are palpably recognizable by their solid-elastic consistence and their pulsa-
tion 
The phrenic nerve should be looked for and spared as well as the left vagus nerve 
and its branch, the recurrent nerve, passing over the ventral side of the aortic arch 
Any minor hemorrhages due to tissue biopsies can be staunched with the coagu-
lation suction-pipe If there are any lesions of the pleura, drainage may be applied 
A post-operative x-ray check of the thorax is recommended to trace any (small) pneu-
mothorax Sometimes, in spile of careful examination, no lymph nodes are found 
In such a case, mediastinal tissue biopsies can be taken, especially when the tumour 
is centrally placed, to trace tumour infiltration by direct invasion This procedure can 
lead to nerve damage and should only be resorted to if neoplastic tissue is suspected 
on the basis of palpation. 
After every biopsy the forceps is rinsed in physiological salt, to prevent any re-
implantation of tumour cells in the wide-meshed connective tissue and fatty tissue 
A systematic, numbered inventory of the biopsies according to location of origin 
contributes to a precise determination of the spread of the metastatic pi ocess according 
to fig 4-1 
Care must be taken not to damage or crush unnecessarily biopsy material, since 
that is the only way the pathologist can determine intra or extranodal spread in case 
of metastatic tumour involvement (See VII 1 2 and VIII 2 1) Biopsies are taken from 
the following nodes in the anterior mediastinum in following order nodes found along 
the left phrenic nerve, in front of and above the aortic arch, and under and in the 
aortic arch If cervical mediastinoscopy docs not yield any nodes, the aortic window 
can be bimanually palpated via this approach The right index finger approaches the 
aortic window via the vertical skin incision along the trachea, the left index finger 
via the parasternal skin incision In this way the right index finger can give some 
counter-pressure to the left index finger If the thorax is long or one's fingers are too 
short, this method does not work 
Ad8 After careful hemostasis the mediastinoscope is retracted The intercostal muscle 
may be closed, but this is not necessary The pectorahs major muscle is sutured, and 
the skin is closed with autosuture material A suction drainage may be omitted 
V.5 Post-operati\e procedure 
In general, parasternal mediastinoscopy is tolerated well, even in advanced old age. 
Antibiotic profylaxis is routine Only in case of damaging the pleura a thorax X-ray 
is advised Skin sutures may be removed after seven days 
V.6 Notes 
Jolly, 1980, advises surgeons to incise the mediastinal pleura and to introduce the 
mediastinoscope via the parasternal mediastinoscopic procedure into the pleural cavi-
ty when it is expedient to inspect the left hilus or the lung itself. 
In general parasternal mediastinoscopy does not present any large technical difficul-
ties The surgeon should be prepared for anatomical variations which may occur Past 
mediastinal infections and previous mediastinal operations may lead to fibrosis This, 
27 
too, may make the procedure difficult or impossible. The vagus nerve deserves special 
attention. If it is stimulated during the endoscopic exploration of the aortic arch, it 
may lead to a fall in blood pressure and to bradycardia. This vasovagal reflex can 
even lead to cardiac arrest. Both anesthesist and surgeon should know how to deal 
with any complication. 
Page, 1980, sometimes resects a small segment of the second costal cartilage. He 
also invariably ligates the internal mammary artery and veins. This has not been found 
necessary in any of the study groups presented here. 
Dyon, 1978, described the method for diagnostic purposes in children with medias-
tinal enlargement as 'médiastinoscopie antéro-latérale' and entered the mediastinum 
by opening the right or left third intercostal space. There were no complications. 
Lacquet, 1978, recommends combined cervical mediastinoscopy and left paraster-
nal mediastinotomy in left upper lobe carcinoma. 
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CHAPTER VI 
COMPLICATIONS OF PARASTERNAL 
MEDIASTINOSCOPY 
VI. 1 Introduction 
Complications are inherent to the practice of surgery. Their gravity and frequency 
partly determine the risks of any surgical procedure Λ diagnostic procedure should, 
if possible, be conducted with as few risks as possible and should not be too complicat­
ed The exploration of the anterior mediastinum involves important structures such 
as veins, arteries and nerves, as well as the mediastinal pleura Damage may be caused 
to any of these structures. Up to publication, very few complications have been de­
scribed in the literature 
VI.2 Complications of parasternal mediastinoscopy 
VI2 1 Hemorrhages 
Endoscopic exploration and biopsy can cause minor hemorrhages. These are most 
often venous of nature and stop either spontaneously, or by gauze packs or electro­
coagulation Hemorrhages from large vessels may occur If possible, the internal 
mammary artery and veins, and the intercostal arteries and veins should be spared, 
but if necessary, they can be ligated without difficulty. The internal mammary artery 
can be pushed laterally using a retractor during the exploration 
VI2 2 Lesions of the mediastinal pleura 
Opening the mediastinal pleura may cause (partial) pneumothorax A small opening 
in the mediastinal pleura docs not have to be closed if the wound is closed in layers 
A small pneumothorax will be resorbed spontaneously within a few days. Suction 
drainage is seldom necessary A post-operative x-ray of the thorax affords sufficient 
guarantee that a pneumothorax or hemothorax has not been missed This complica­
tion has not occurred in the present series 
VI2 3 Injuries to nerves 
The phrenic nerve, the vagus nerve and the left recurrent laryngeal nerve fall within 
the scope of parasternal exploration of the anterior mediastinum (For their course, 
see the chapter on anatomy ) Stimulation and/or injuries of the phrenic nerve may 
lead to permanent left-sided diaphragmatic paresis. Stimulation and/or injuries of the 
recurrent nerve may give rise to temporary or permanent hoarseness Stimulation of 
the vagus nerve can lead to a fall in blood pressure, bradycardia and extremely rarely 
cardiac arrest These complications have not been described so far 
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Vi.2.4 Infeclion 
Mediastinitis and/or mediastinal formation of abscesses have not been described 
so far. A wound infeclion has been observed once in the present series. No deaths 
have so far been reported. 
V1.3 Summary 
Any theoretically possible complications at parasternal mediastinoscopy are men-
tioned. The literature mentions only sporadical minor hemorrhages. In our series mi-
nor hemorrhages, one case of paresis of the left phrenic nerve and one case of paresis 
of the left recurrent nerve were observed. As it is, the technique of parasternal medias-
tinoscopy seems to be a safe procedure. 
30 
CHAPTFR VII 
RE VIEW OF RESULTS OF SURGICAL TR E ATM ENT IN 
LUNG CARCINOMA WITH MEDIASTINAL 
METASTASIS. SURGICALSALVAGE* 
VII.l Introduction 
The prognosis of resectable lung carcinoma with metastasis in mediastinal lymph 
nodes is still controversial In order to assess properly the benefits versus the risks 
of surgical treatment, the survival rate should be related to the mortality rate as a 
result of explorative thoracotomy and resection The per cent difference is expressed 
as the surgical salvage (Paulson 1971 ) The surgical salvage of N2 carcinomas is calcu­
lated by subtracting the percentage of operative mortality** at resection for N2 carci­
noma and the percentage of operative mortality at explorative thoracotomy only, from 
the 5-year survival rate of resected N2 carcinoma Improved patient selection will 
increase the resection rate (Reyndcrs 1965) Some of the following procedures have 
been suggested in the pre-opcrativc selection of patients plano(tomo)graphy, CT-
scanmng, pulmonary arteriography, thoracoscopy, fibcr-bronchoscopy, transthoracic 
and Iranscannal cytological puncture, and mediastinal exploration through cervical 
mediastinoscopy, parasternal mediastinoscopy and parasternal mediastinotomy 'Sur­
gical salvage' will concern mainly patients having primary lung carcinoma with me­
diastinal lymph node metastasis (from now on referred to as carcinoma with N2 status, 
in accordance with the TNM-system, AJC 1983) 
Substantial differences in patient selection and material make it very difficult to 
compare operative results after resection for lung carcinoma with N2 status. To facili­
tate the comparison of separate scries, Paulson introduced the concept of 'surgical 
salvage', based on resection, survival and operative mortality rates, which can all be 
measured and expressed in terms of numbers and percentages Differences in patient 
selection will be discussed separately 
The evaluation of resection results in N2 status carcinomas is based on the following 
considerations. 
a the percentages of explorative thoracotomies and related operative mortality, 
b the 5-year survival after resection for N2 status carcinoma, 
с the percentage of operative mortality in resection of N2 status carcinomas, 
VI11 I Definitions of terms used in chapters VII and VIII 
1 Operabihty. operable means that a potentially curative resection can be expected. 
The term 'curative' implies that the mediastinal lymph nodes and the adjacent 
organs are not involved 
2 Inoperability inoperable means that a curative resection cannot be expected 
3 Resectability resectable means that at thoracotomy curative or palliative resection 
* surgical salvage = surgical salvage according to Paulson, 1971 
** operative morlalil) = pen posl-operalive morlahly 
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of the tumour is possible 'Palliative' means either that the mediastinal lymph nodes 
are involved or that adjacent organs are involved as a result of tumour extension 
4 Irresectabihty irresectable means that at thoracotomy no resection is possible, 
technically speaking 
5 Explorative thoracotomy means thoracotomy at which it is established that cura-
tive nor palliative resection is possible, in the CWZ hospital it means that curative 
resection is impossible (exploration but no resection) 
6 Operative mortality = pen/post-operative mortality = mortality at surgery or 
within 30 days after surgery 
7 Early mortality = operative mortality within 30 days after surgery, or after 30 
days in the case of patients who did not leave hospital 
8 Overall operative mortality = operative mortality comprising mortality at resec-
tional and non-resectional surgery 
9 5-ycar survival. In the present series the actuarial 5-year survival rates are calculat-
ed according to the Kaplan-Meier method (1958) 
10 Intranodal lymph node involvement means that lymph node metastasis is confined 
to the node 
11 Pcrmodal lymph node involvement means that the capsule and/or surrounding 
fatty tissue are involved 
VII.2 Explorative thoracotomy and related operative mortality 
It seems to be universally accepted that in the case of non small-cell lung carcinoma, 
surgery offers the best chances for survival (Watson 1956, Overholt 1957, Bignall 
1958, Jenny 1962, Boucot 1967, Jones 1967, Paulson 1967, Higgens 1969, Ochsncr 
1969, Shields 1971, Larsson 1973, Kirsch 1976, Lacquet LK 1976, Vincent 1976, Akov-
biantz 1976, Preise 1978, Smith 1978. Narukc 1978, Lacquet A 1979, Rubinstein 1979, 
Ashraf 1980, Pearson 1982, Martini 1983, Bosch van den 1983). 
In spite of the efforts made to diagnose the disease in an early stage, 50% of patients 
prove clinically inoperable at diagnosis At surgical exploration of patients considered 
clinically operable, the tumour often proves irresectable, or a curative resection ap-
pears virtually impossible because of metastasis to the mediastinum Before mediastin-
oscopy was introduced, the number of explorative thoracotomies was high, making 
up about 40% of the total number of thoracotomies Analyzing the data of 39 authors, 
Maassen found an overall percentage of explorative thoracotomy of 37% An explora-
tive thoracotomy must be viewed as a major operation involving a certain degree of 
morbidity and mortality 
Table 7-1 lists a number of authors who in the last two decades have published 
data about the number of patients in their senes who proved to be explored for bron-
chus carcinoma, and the corresponding mortality rates 
During the last 20 years the operative mortality from explorative thoracotomy has 
remained remarkably constant, about 5% in the group where in the pre-operative selec-
tion mediastinoscopy was performed to determine operabihty Before mediastino-
scopy was introduced, the average operative mortality in the only-explorative-thoraco-
tomy group was 9 6% Reynders found an operative mortality of 12% in the overall 
statistics of 1065 explorative thoracotomies Since explorative thoracotomy and palha-
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tive resection do not in effect prolong life expectancy, it is essential that the operability 
of a tumour is determined as accurately as possible. (Gibbon 1953 and 1955, Kirklin 
1955, Ochsncr 1960, Reynders 1964 and 1965, Schaar van der 1965, Hasler 1966, Jen­
sen 1966, Paulson 1967, Gibbons 1972, Larsson 1973 and 1976, Lacquet 1975 and 
1976, Carlens 1982, Pearson 1982.) 
Table 7-1 shows that since cervical mediastinoscopy has been introduced for assess-
Table 7-1. Only explorative thoracotomy for bronchus carcinoma, and related operative mortality and 
resection rates before and after the introduction of cervical mediastinoscopy 
First author Year Number 
at 
surgery 
N 
NO MEDIASTINOSCOPY PERFORMED 
Sorensen 
Burford 
Ochsncr 
Barret 
Sensemg 
Lacquet ** 
Average mortality: 
1956 
1958 
1960 
1963 
1963 
1976 
458 
603 
525 
824 
624 
124 
CERVICAL MEDIASTINOSCOPY PERFORMED 
Bergh 
Schaar van der 
Schaar van der 
Palva 
Paulson 
Pearson 
Larsson 
Viikan 
Overholt 
Akovbiant/ 
F reise 
Lacquet 
Wilkins 
Ashraf 
Nohl-Oser 
Bosch van den 
Present series 
Average mortality-
1965 
1965 
1965 
1969 
1971 
1972 
1973 
1974 
1975 
1976 
1978 
1978 
1978 
1980 
1980 
1983 
1985 
219 
72 
104 
57 
886 
356 
313 
644 
2627 
201 
471 
1 8 1 * " 
327 
638 
663 
1317 
184 
Irrcscctabihty 
N 
138 
247 
169 
432 
275 
25 
40 
5 
7 
12 
177 
15 
36 
86 
778 
25 
38 
3 
78 
19 
18 
150 
25 
О 
О 
30,1 
41.0 
32,2 
52,4 
44,1 
20,2 
18,3 
6,9 
6,7 
21,1 
20,0 
4,2 
11.5 
13,4 
29,6* 
12,4 
8,1 
1,7 
23,9 
3,0 
2,7 
11,4 
13,6 
Resection 
rate 
0 / 
69,9 
59,0 
67,8 
47,6 
55,9 
79,8 
81,7 
93,1 
93,3 
78,9 
80.0 
95,8 
88,5 
86,6 
70,4 
87,6 
91,9 
98,3 
76,1 
97,0 
97,3 
88,6 
86,4 
Recorded 
operative 
mortality 
N 
22 
28 
17 
41 
4 
0 
9 
1 
7 
1 
" o 
8,9 
16,6 
3,9 
14,9 
9,6% 
10,0 
0,0 
5,1 
2,6 
4,7 
4,0 
5,0°,, 
* not all patients had mediastinoscopy 
** after negative Daniels biopsy (supraclavicular, prescalenic) 
*** only central tumours 
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ing the operability of bronchus carcinoma, the percentage of explorative thoracoto­
mies has dropped considerably, varying from 1,7"0 to 23,9"0. 
The nodes in the aortic window and round the aortic arch cannot be reached at 
cervical mediastinoscopy These, however, form an important drainage pathway for 
the left lung. This explains why the yield at mediastinoscopy from left-lung tumours 
is lower than that from right-lung tumours All patient series show that the use of 
cervical mediastinoscopy has decreased considerably the number of explorative thora­
cotomies (Seechapter VIII ) 
П 3 J Survival and operative mortality in resection for lung < arcinoma with N2 status. 
Surgical salvage 
Publications on the resection of lung carcinomas with N2 status fall into two groups. 
In the one group the N2 status was established at thoracotomy (whether or not pre­
ceded by negative mediastinoscopy) or after histopathological examination of the re­
sected specimen (table 7-2) In the other group the N2 status had already been estab­
lished at mediastinoscopy (table 7-3) In order to assess properly the benefits of surgical 
treatment, as many data as possible about N2 lung carcinomas have been gathered 
from the literature to calculate the surgical salvage in the group of N2 carcinomas 
Table 7-2 shows data concerning the resected lung tumours in which the N2 status 
was established at thoracotomy The 5-year survival rates range from 0 o
o
 to 29,1% 
The total number of N2 lung carcinomas in this group is 1732 The average 5-year 
survival rate is 9.7°„ I welvc authors mention the operative mortality that may result 
from resection for N2 lung carcinoma The average operative mortality in this group 
of 1076 patients is 11,3"0 When the average survival is set oft against the average 
operative mortality in order to calculate the surgical salvage, the salvage proves to 
be implicitly negative, even if the average 5,0% operative mortality related to thoraco­
tomy is left out of account (table 7-1) 
Shields, 1975, and Naruke, 1978, do not specify operative mortality rales Borne, 
1965, Palva, 1969, Kirsh, 1976, Preise, 1978, and Abbey Smith 1978, specify only the 
overall operative mortality rates Using these, the operative mortality m this group 
of resected N2 lung carcinomas was calculated as an average of 11% for the whole 
patient group (excluding Naruke and Shields) Surgical salvage remains implicitly neg­
ative This means that when the benefits and risks of surgical treatment are weighed 
in accordance with the definition of surgical salvage proposed by Paulson, 1971, selec­
tivity must be the basis for surgery in this group of lung carcinomas with N2 status 
However, there are substantial variations in the results of the respective authors They 
will be discussed separately in order to arrive at an accurate evaluation. Attention 
will also be paid to the intra or perinodal growth of metastases in lymph nodes and 
to the exact location of lymph node metastases in the mediastinum 
Nohl, 1951, 1956, 1962, found a 4-ycar survival of 9,8% in resected N2 lung carcino­
mas The operative mortality in this group is 11%. The percentages of explorative 
thoracotomies and related mortality are not specified Surgical salvage was negative. 
Nohl claims that once the mediastinal lymph nodes have become metastatically in­
volved, the tumour has spread beyond the limits of adequate surgical resection In 
this series the pre-opcrative selection criteria and the resection rate are not specified 
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Table 7-2 Survival and mortality of patients with N2 lung carcinomas who underwent resection and in 
whom the N2 status was established at thoracotomy (whether or not preceded by negative cervical medias­
tinoscopy) 
First author Year N2 cases 5 year- operative overall mcdiasli-
rcscclcd survival mortality operative noscopy 
mortality performed 
Nohl 
Bergh 
Borne 
Pal va 
Ramsey 
Paulson 
Vnkari 
Shields 
Kirsh 
Kirsh 
Paulson 
Vincent 
l·reise 
Narukc 
Abbey Smith 
Rubinstein 
Ashraf 
Nohl-Oscr 
Pearson 
Martini** 
Present scries 
Total 
1962 
1965 
1965 
1969 
1969 
1971 
1974 
1975 
1976 
1976 
1976 
1976 
1978 
1978 
1978 
1979 
1980 
1980 
1982 
1983 
1985 
N 
82 
61 
17 
2 
83 
195 
31 
268 
20 
69 
219 
52 
129 
64 
56 
46 
53 
58 
57 
151 
17 
1732 
N 
8 
3 
0 
0 
18 
13 
3 
24 
0 
17 
13 
2 
17 
12 
16 
5 
2 
2 
13 
0 
168 
О 
9,8 
4,8 
0 
0 
217 
6,7 
9,7 
90 
0 
24 6 
5,9 
3,8 
13.2 
18,8 
28,6 
10,9 
3,8 
3,4 
22,8 
29,1 
0 
9,7 
Ν 
9 
19 
16 
15 
17 
6 
10 
9 
10 
5 
2 
4 
О 
11,0 
30,2 
19.3 
7,7 
7,8 
11,5 
21.7 
17,0 
17,2 
8.8 
1.3 
23.5 
1 
* Mean overall operative mortality combined with operative mortality in the resected lung carcinomas 
with N2 status 
'negative mediastinoscopy' means that no lymph node metastases were found in the mediastinum at 
mediastinoscopy 
** not included in the'totals' 
Twelve authors spccity operative mortality in resections of lung carcinomas with N2 status 11,3"0 on the 
average 
To determine the N2 status of a lung carcinoma the Salzer classification was used 
(Saber, 1951) and subsequently modified. Mediastinoscopy was still uncommon 
Bergh, 1965, removed all ipsilateral mediastinal lymph nodes in 179 resectable lung 
carcinomas and this yielded 63 patients with N2 status Standard resection yielded 
an operative mortality of 6,0% (8/133), extended resection (stage III according to the 
Salzer classification modified according to Nohl) yielded an operative mortality of 
30,2о/() (19/63) 
Bergh found a markedly low operative mortality in standard resections in patients 
under age 60 3.8% The operative mortality in the case of explorative thoracotomy 
is 10%. The 5-year survival in resected N2 status lung carcinomas is 4,8%. It is obvious 
that surgical salvage is negative The author accepts Nohl's claim that long-term sur-
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14 
8.9 yes 
yes 
6 
6 
13.4 
6,5 
yes 
yes 
yes 
yes 
1,0",,* 
vivai in bronchogenic carcinomas is related to the stage in which lymphatic metastasis 
occurred He also points out the significance of intranodal and perinodal growth of 
lymph node metastases (table 7-4) The 5-year survival m resected lung carcinomas 
is 43% when nodal involvement is still in the intranodal stage, but only 4% when nodal 
involvement has reached the perinodal stage (Larsson 1973 and Carlens 1982 confirm 
this) 
Table 7-4 Prognostic significance of intra or perinodal metastatic involvement in bronchogenic carcinoma 
(N2 or comparable stage) Bergh (stage 2 and 3 Saber classification, 1965) Larsson (N2 status 1973) 
Bergh 
Larsson 
1965 
1973 
Operative mortality 
intranodal perinodal 
2,37= 5,4"0 15,62 = 24,2",, 
1 8 = 12,5° „ 3 2 6 - 11,5",, 
Survival 
intranodal 
16 37 - 43,2°/, 
5/8 = 62,5°/ 
perinodal 
3 62 = 4,8"
 0 
0 26 = 0 "„ 
Borne, 1952, 1965, was the first to recognize that the location of metdstatically 
involved lymph nodes also affects the prognosis for 5-year survival after surgical resec-
tion He claims that the presence of tumour cells in the interlobar lymphatic sump 
nodes (N1 status) should be no reason to expect poor survival rates, but that when 
lymph node metastases have spread beyond this level m the mediastinum (N2 status), 
the patient will probably die within a few years, even after resection Of 17 patients 
who underwent resection for N2 status lung carcinoma, 16 died within 15 months, 
and 1 died within 2 years Here, too, surgical salvage is negative In Borne's view 
surgical treatment of all lung carcinomas -and that includes squamous cell carcinomas-
has a very poor survival prognosis when lymph node metastases have reached this 
level Only 5 (13,8/0) of 36 patients with squamous cell carcinoma of the lung and 
with metastatic lymph node invasion of both N1 and N2 status, survived 5 years 
The operative mortality was not included in this series No pre-operative cervical me-
diastinoscopy was performed. An accurate analysis of the exact location of metastatic 
lymph nodes at intrapulmonary and mediastinal level is available Life expectancy 
is extremely poor in the case of perinodal tumour growth, even in the case of bronchus 
carcinoma classified as stage II (Salzer classification) 
Palva, 1969, found no 5-year survival in resected N2 status lung carcinomas The 
overall operative mortality is 8,9% All patients had a negative cervical mediastino-
scopy prior to thoracotomy The resection rate in this series is 79% There are no 
data available about intranodal or perinodal metastatic tumour growth, nor about 
the exact mediastinal location of metastatic lymph nodes Surgical salvage is negative. 
Ramsey, 1969, found a 5-year survival of 21,7% in 83 resected N2 status lung carci-
nomas, excluding operative mortality (19,3%) 
Table 7-5 shows the survival that Ramsey found in resected lung carcinomas with 
hilar and/or mediastinal lymph node metastasis If we apply the concept of surgical 
salvage according to Paulson, the surgical salvage in this series is also negative He 
concludes that these results seem to indicate the inoperabihty of lung carcinomas with 
hilar lymph node metastasis (= N1 status) as well as those with mediastinal lymph 
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Table 7-5. Ramsey, 1969 Operative mortality and 5-year survival after resection in bronchogenic carcinoma 
with only positive hilar (N1) or positive hilar and mediastinal (N2) lymph nodes, identified at thoracotomy. 
resected operative 5-year 
lung carcinoma mortality survival 
127 25,127 = 19,7° „ 23/127 = 18,1°0 
node metastasis ( = N2 status). 
Ramsey does not distinguish between intranodal or perinodal lymph node metas-
tases, nor does he give the exact location of these metastases in the hilus or the medias-
tinum. 
Viikari, 1974, performed resection in 31 patients with lung carcinoma. All of them 
underwent pre-operative cervical mediastinoscopy, but showed no evidence of medias-
tinal metastasis. The 5-year survival rate is 9,7% (3/31). The operative mortality in 
this group and in the group of 29 only explorative thoracotomies are not mentioned. 
Surgical salvage cannot be expressed in terms of numbers and rates. There are no 
data on the intranodal or perinodal growth of lymph node metastases, nor on their 
exact location in the mediastinum. 
Paulson, 1971, emphasizes how important the proper selection is in the surgical 
treatment of lung carcinoma. He uses tomography, pre-operative mediastinal explora-
tion and pulmonary angiography for determining the resectability and the extent of 
the resection. Complete pre-treatment assessment must be the basis for selection in 
surgical treatment of lung carcinoma. An accurate pre-treatment evaluation based 
on objective evidence will result in optimal pre-operative TNM-staging of the patient. 
Mediastinal exploration is essential for determining the N2 status. Paulson describes 
two groups of patients who underwent resection for N2 status lung carcinoma. In 
both groups the N2 status was established at thoracotomy. In the first group, compris-
ing 146 patients from the period 1950-1960, the resection rate was 72%, mediastinal 
exploration being then uncommon. The 5-ycar survival is 8%; surgical salvage is nega-
tive. In the second group, comprising 105 patients from the period 1960-1969, all pa-
tients had pre-operative mediastinal exploration by cervical mediastinoscopy. In the 
latter group the resection rate increases to 87% and the 5-year survival remains con-
stant at 6%. From this evidence Paulson concludes that if in lung carcinoma the me-
diastinal lymph nodes are involved, there are few grounds for surgical resection. He 
also claims that improved pre-operative patient selection has increased the overall 
surgical salvage. (His data show an increase from 13% to 30% in 2 10-ycar groups). 
In 1976 Paulson analysed the 13 5-year survivors in a group of 219 patients with re-
sected N2 status lung carcinomas. All survivors turned out to have metastatic lymph 
nodes ipsilaterally situated at a low mediastinal level (tracheobronchial), with intrano-
dal metastasis. The primary lung tumour turned out to be in every case a squamous 
cell carcinoma. 
Shields, 1975, reports a 5-year survival of 9,0% in 268 resected lung carcinomas 
with N2 status. This scries comprises only those resections that were expected to be 
curative. The percentage of explorative thoracotomies, the resection rate and the oper-
ative mortality related to resection and explorative thoracotomy are not mentioned. 
Shields did not mention the operative mortality rates of his series. He does not give 
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any data about the pre-opcralivc selection criteria Shields (table 7-2) finds a higher 
5-ycar survival rate for resected N2 carcinomas that fall into the histological category 
of squamous cell carcinomas Shields accepts the dismal prognosis of carcinoma of 
any histological cell type with mediastinal lymph node metastasis, but states that in 
the case of squamous cell carcinoma, the presence of mediastinal lymph node metasta-
sis is no absolute contra-indication to resection 
In 1977 Shields reports a 5-ycar survival of 7,1"0 in 42 resected T2N2 lung carcino-
mas. The survival of 3 T3N2 lung carcinomas and 9 T1N2 lung carcinomas is not 
mentioned There are no data available about the intranodal or pennodal growth 
of the lymph node metastases, nor about the exact mediastinal location of these lymph 
nodes Since the relevant data arc lacking, the surgical salvage cannot be calculated 
Kirsh, 1976, applies post-operative irradiation to 69 resected N2 lung carcinomas, 
and reports a 5-year survival rate of 24,6°^ On the other hand, the 5-year survival 
rate of 20 resected N2 lung carcinomas that were not post- operativcly irradiated was 
0% Kirsh selects those N2 lung carcinomas where resection could be expected to be 
'curative' The operative mortality that is related to surgical treatment of N2 lung 
carcinomas is not mentioned The surgical salvage cannot be calculated, because essen-
tial data are lacking· the operative mortality as a result of resection for N2 lung carcino-
ma, the percentage of explorative thoracotomies, and the related operative mortality 
The overall operative mortality m all thoracotomies is 6% This rate was used to calcu-
late the average surgical salvage. Although Kirsh rejects the pre-operative selection 
for the evaluation of the operability of lung carcinoma by means of mediastinal explo-
ration, he says that there is an indication for operation in some patients with N2 lung 
carcinoma This implies a high degree of selection He states, that no patient who 
had a thoracotomy showed any radiological evidence of mediastinal or subcarmal 
lymph node enlargement To increase the survival rate in the resection for lung carcino-
ma with N2 status, the survival rate ofpalhativc resections and explorative thoracoto-
mies and the related operative mortality were not included in the definitive calculation 
of the survival rate of resected N2 lung carcinomas This high survival rate for thoraco-
tomy and resection of N2 lung carcinomas is built on false premises burthcrmore, 
no mention is made whether the lymph node metastases in the 89 resected patients 
were intranodal or pennodal Their exact location in the mediastinum is not reported 
either It is certainly debatable whether patients should be excluded from thoracotomy 
merely on the basis of radiological evidence of mediastinal or subcarmal lymph node 
enlargement. Objective evidence of mediastinal lymph node metastasis, obtained 
through mediastinal exploration, is to be preferred in the evaluation of the operability 
of lung carcinomas 
Vincent, 1976, found a resection rate of 52% in 567 thoracotomies which were not 
preceded by mediastinal exploration and which were expected to be curative The oper-
ative mortality in explorative thoracotomy is 4,1% in his series The survival rates 
of lung carcinomas with positive hilar and/or mediastinal lymph nodes are extremely 
low The operative mortality in resection of N2 lung carcinomas is 11,5% Surgical 
salvage is negative The exact mediastinal location of positive lymph nodes, found 
at resection, is not mentioned The intranodal or pennodal growth of lymph node 
metastases is not mentioned either. Vincent suggests that once a tumour has demon-
strated a propensity for dissemination, it rarely limits the capacity to the immediate 
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vicinity of the primary tumour Vincent concludes from his retrospective study that 
the pre-operative selection for the evaluation of the operabihty of lung carcinoma 
by means of mediastinal exploration is a precondition for minimi/ing the number 
of explorative thoracotomies 
Preise, 1978, found a resection rate of 91,90/0 in 471 thoracotomies. This seems to 
imply a high degree of pre-operative patient selection in evaluating operabihty. The 
selection criteria are not mentioned No pre-operative mediastinal exploration was 
performed The 5-year survival of resected N2 status lung carcinomas (n= 129) is 
13.2%, while the operative mortality in all thoracotomies is 13,4°^ Based on these 
rates, the surgical salvage is negative The operative mortality related to resection of 
N2 lung carcinomas is not reported The operative mortality in the case of explorative 
thoracotomy is 2,6%, which makes the surgical salvage even worse There are no data 
on the exact location of mediastinal lymph nodes which are involved, nor about the 
intranodal or perinodal growth of lymph node metastases. 
Abbey Smith, 1978, recommends the use of cervical mediastinoscopy as a routine 
examination of patients aged 65 and over, in whom mediastinal lymph node metastasis 
is suspected. In younger patients (aged 52 on the average in his scries) pre-operative 
mediastinoscopy would have yielded mediastinal lymph node metastases in only a 
small number of cases In just 12 of 417 lung resections would mediastinoscopy have 
yielded evidence that could be considered a definitive contra-indication to surgical 
treatment In evaluating the operabihty of young patients with N2 lung carcinoma, 
he applies the criterion that lymph node involvement should still be ipsilateral, low 
paratracheal, at azygos, subcannal or subaortic level, and the growth of the nodes 
should be intranodal (We regard subcannal lymph nodes as bilateral and consequent-
ly, unlike Abbey Smith, as unamenable to surgery) Compared with others, this scries 
of 417 thoracotomies has a remarkably low percentage of mediastinal lymph node 
metastases (N2 status)· 13,4% (56/417) The 5-year survival alter resection of N2 lung 
carcinomas is 28,6%. In all 5-year survivors with N2 status (except one) the growth 
of lymph node metastases was only intranodal In none of these resections of N2 status 
lung carcinoma, there is much information on the exact location of in volved mediastin-
al lymph nodes or on the intranodal or pennodal growth of the lymph node metastases 
Abbey Smith has a resection rate of 97,5% Since no mediastinal exploration was per-
formed in the pre-operative evaluation of the operabihty of lung carcinomas, this per-
centage is indicative of a high degree of applied pre-operative selection. In the pre-
operative evaluation bronchoscopical findings were correlated with other evidence 
of mediastinal lymph node metastasis In 1964. Abbey Smith slated- 'My selection 
is really based on pre-operative findings rather than per-operative.' He docs not discuss 
his selection criteria, however Operative mortality is specified only for the group of 
thoracotomies as a whole. 6,5% The percentage of explorative thoracotomies is very 
low (2,5%) If very strict pre-operative selection criteria are set up in this way for 
the evaluation of the operabihty, surgical salvage may well become positive in carcino-
mas with N2 status where mediastinal lymph node involvement is limited to an intrano-
dal growth If these entena can be based on objective pre-operative evidence, they 
will get due recognition 
Naruke, 1976, gives a detailed survey of the mediastinal location of lymph node 
metastases found at the resection of lung carcinomas whose N2 status was established 
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at thoracotomy, in whom no prc-operative cervical mediastinoscopy had been per-
formed The pre-operative selection criteria are based on clinical staging, in accordance 
with the system of the Japanese Lung Cancer Society The resectabihty rate is 82% 
The overall operative mortality in resection is 6,9% The operative mortality related 
to explorative thoracotomy is not mentioned. The 5-year survival of 92 resected pa-
tients with N2 lung carcinoma is 6,6% Surgical salvage is negative Naruke, 1978, 
out of a total of 468 resections, performed 270 curative resections or resections that 
were expected to be curative The overall operative mortality is 5,1%. The percentage 
of explorative thoracotomies is not mentioned The survival rates are specified only 
in the group of N2 lung carcinomas who had a potentially curative resection (n = 
64) In this group there are 12 (18,8%) 5-year survivors. Naruke selects the survival 
rates post-operatively (64 resections of N2 lung carcinomas) These have a 5-year sur-
vival rate of 18,8%. With respect to left-lung tumours Naruke reports no 5-year survi-
vors with resected N2 lung carcinomas and subcannal lymph node involvement Surgi-
cal salvage in the series from 1976 is negative Surgical salvage in the series from 1978 
cannot be calculated because the relevant data are lacking. The exact location of me-
diastinal lymph node metastases is indicated. There are no data on the perinodal or 
intranodal growth of metastases involving lymph nodes Naruke finds that adjuvant 
therapy, when applied post-operativcly to tumours which were thought to be amenable 
to surgery, had no effect on the survival rate 
In 69 stage-Ill lung carcinomas Lacquet LK, 1977, finds a median survival of 17 
months for those with mediastinal lymph node involvement, of 13 months for those 
with involvement of other intrathoracic organs, and of 9 months for those with invol-
vement of mediastinal lymph nodes and other intrathoracic organs There are no 
5-year survivors Surgical salvage is negative 
Rubinstein, 1979, does not believe that in the case of squamous cell carcinoma 
spreading from the lung, the presence of mediastinal lymph node metastases in itself 
constitutes an absolute contraindication to surgical treatment. In this group the 5-year 
survival is 25% (3/12) This view does not apply to adenocarcinomas and carcinomas 
of other cell types The percentage of explorative thoracotomies in 202 thoracotomies 
is 16,3%, while that in the case of squamous cell carcinomas is 18,9%. The related 
operative mortality is not mentioned. In 46 resected N2 lung carcinomas, the 5-year 
survival is 10,8%. Operative mortality in resection of N2 carcinomas is 22,5%. Surgical 
salvage in the group of N2 resections as a whole is negative. In the group of N2 status 
squamous cell carcinomas with a 25% 5-year survival (operative mortality related to 
resection is 21,7% and mortality at the 18,9% explorative thoracotomies is not men-
tioned) surgical salvage may be expected to turn out negative. The pre-operativc selec-
tion criteria in the evaluation of the operability of lung carcinoma are not mentioned 
Mediastinoscopy was not performed There are no data on the exact location of me-
diastinal lymph node metastases, nor on intranodal or pcnnodal tumour spread 
Ashraf, 1980, invariably performs cervical mediastinoscopy in the pre-opcrative 
evaluation of the operability of lung carcinoma, in order to minimize the number 
of explorative thoracotomies. After negative mediastinoscopy, 638 patients were re-
sected, the resectabihty rate being 97,1% The overall operative mortality is 5,5% The 
5-year survival of the 53 resected N2 lung carcinomas is only 3,8% (2/53) Ashraf 
points out that the operative mortality in his series triples when the tumour develops 
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from stage A to stage С (Salzer classification, modified according to Nohl) Surgical 
salvage is negative There arc no data available about the exact location of mediastinal 
lymph node metastases, nor about the intranodal or pennodal growth of lymph node 
metastases 
Nohl-Oser, 1980, has a resectabihty rate of 97,3% Cervical mediastinoscopy is in­
variably performed in the prc-operative selection for the evaluation of the opcrabihty 
of lung carcinoma In 668 resections, performed after negative mediastinoscopy, 58 
patients proved to have mediastinal metastasis In this group of N2 lung carcinomas, 
the 5-year survival after resection is 3,4% Related operative mortality is 17,2% The 
mortality related to explorative thoracotomies is not mentioned Surgical salvage is 
negative Nohl-Oser emphatically rejects the suggestion that mediastinoscopy should 
deprive a patient with lung carcinoma of a chance of cure, arguing that on the one 
hand the survival rale is uniformly bad once mediastinal lymph nodes have become 
involved and, on the other, that operative mortality triples when patients with medias­
tinal lymph node metastasis undergo resection There are no data available about 
the intranodal or pennodal growth of lymph node metastases, nor about the exact 
location of the mediastinal lymph node metastases 
At thoracotomy, performed in each case after negative cervical mediastinoscopy, 
Pearson, 1982, found mediastinal lymph node metastases in 62 patients The location 
of the majority of these metastases was anteriorly mediastinal, subaortic, posteriorly 
subcarmal or para-oesophageal, and consequently they could not be reached during 
cervical mediastinoscopy. The resectabihty rate is 91,9% (n = 57) Only 43,9% (25/57) 
of resections could be considered curative, ι e no macroscopic tumour was left behind, 
the ipsilatcral mediastinal nodes were removed too The operative mortality is 8,8% 
(5 57) The actuarial 5-year survival rate of all 62 patients is 22,8% (operative mortality 
included) Surgical salvage is positive when, after negative mediastinoscopy, the N2 
status is established at thoracotomy and resection is performed It is not mentioned 
whether these lymph node metastases seemed macroscopically positive or whether 
they proved positive after hislopathological examination No data on the intranodal 
or pennodal growth of lymph node metastases are presented Their exact mediastinal 
location is indicated in detail Twenty-five patients had post-operative irradiation, 
4 had pre and post-operative irradiation, and 3 had only pre-operative irradiation 
The remaining patients received no adjuvant therapy as long as they remained clini­
cally free of tumour Pearson observes that in a total of 141 thoracotomies (see also 
table 7-3), there were only 13 absolute 5-year survivors, yielding an absolute 5-year 
survival rate of 9,2% (13/141) In the group of patients with negative mediastinoscopy, 
there arc 8 absolute 5-year survivors, yielding an absolute 5-year survival rate of 12,9% 
(8/62), surgical salvage turning out just positive Pearson concludes that the 5-year 
survival rates of patients in whom the N2 status was established at mediastinoscopy 
are sigificantly worse than those of patients in whom the N2 status was established 
after negative mediastinoscopy. It should be remarked that a highly selected patient 
base is involved here It took Pearson 17 years to select his series of 141 patients for 
thoracotomy 
Martini, 1983, performed resection that was expected to be curative in 151 (21,4%) 
out of 706 lung carcinomas with evidence of mediastinal lymph node metastasis. All 
carcinomas are staged in accordance with the AJC system The percentage of explora-
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live thoracotomies and incomplete resections of N2 lung carcinomas, and related oper­
ative mortality arc not mentioned In the evaluation of the final results, these groups 
have been left out of account The 5-year survival rate of the 151 potentially curative 
resections is 29,10 0, excluding death from unrelated causes Nearly all patients in this 
group had post-operative irradiation His clinical N2 staging is based on radiological 
evidence of mediastinal lymph node metastasis and on bronchoscopic findings Pre-
operatively, these 151 patients were classified as stage I (90 patients), stage 11(14 pa­
tients) or stage III (47 patients). Thirty-three stage-Ill patients showed clinical evi­
dence of mediastinal lymph node metastasis The survival rale of resected N2 lung 
carcinomas proves to be more favourable in the case of a pre-operative clinical classifi­
cation as stage I or stage II (50",, after 3 years), and poor in the case of classification 
as stage III (8% after 3 years) The operative mortality in the group of resected N2 
lung carcinomas as a whole is not mentioned The average age of these patients is 
60 Surgical salvage cannot be expressed in terms of rates and percentages because 
essential data are lacking In 1980 Martini reports a percentage of explorative thoraco­
tomies involving N2 carcinomas of 54"0, without mentioning the corresponding opera­
tive mortality The percentage of incomplete resections involving N2 lung carcinomas 
is 25,60''0 Survival rates and operative mortality arc not specified The operative mor­
tality within the retrospectively selected group of 151 N2 resections is 1,3"0 To deter­
mine the average 5-year survival rate and the average operative mortality rate, as in 
table 7-2, no data of these 151 N2 resections expected to be curative, were used Martini 
presents no data about the intranodal or perinodal growth of mediastinal lymph node 
metastases. In his series of 151 resected N2 lung carcinomas, 82,1°,, were peripherally 
situated, the first lymph nodes being inlrapulmonary This implies that a rigorous 
pre-selection protocol was used, taking into account that the 'curative' 151 resections 
comprised only 21°,, of the group of lung carcinomas classified as N2. Of importance 
is the observation that in 8 Γ 0 of N2 carcinomas of the left lung, the lymph nodes 
in the aortic window were metastatically involved After 5 to 8 years, the number 
of absolute survivors is 14/151 (9.3C0) Martini finds no different survival rates for 
resected N2 squamous cell carcinomas and resected N2 adenocarcinomas 
Table 7-3 shows the resected N2 lung tumours whose N2 status was established 
at cervical mediastinoscopy The 5-year survival rates vary from 0"
o
 to l8,7"/0 The 
total number of N2 lung carcinomas in this group is 249 The average 5-year survival 
rate is 9,2°,, (23/249). The average operative mortality is 13,Г
и
 (29,222) in the group 
under study When the average survival rate is set off against the average operative 
mortality rate, and the average surgical salvage is calculated, it turns out to be implicit­
ly negative, the average 5,0O/
o
 operative mortality related to explorative thoracotomy 
not included (see table 7-1 ) 
Lacquel 1965, 1966, and Vnkari, 1974, do not mention operative mortality rale 
In table 7-2, as in table 7-3, there are differences in the results of the respective 
authors In order to evaluate the results as accurately as possible, each author will 
be discussed separately The differences in the results of the authors shown in table 
7-3 are smaller than those in table 7-2 Here, too, attention is paid to the intra and/or 
pennodal growth of lymph node metastases and their exact location in the mediastin­
um 
42 
Table 7-3. Survival and mortality of patients with N2 status lung carcmoma who underwent resection 
The N2 status was established at cervical mediastinoscopy 
F-irst author 
Lacquet 
Lacquet 
Pal va 
Gibbons 
Pearson 
Pearson 
Larsson 
Larsson 
Fosburg 
Vnkari 
Lacquet 
Irlich 
Kirschner 
Pearson 
Total 
1965 
1966 
1969 
1972 
1972 
1972 
1973 
1973 
1974 
1974 
1975 
1976 
1981 
1982 
no of cases 
resected 
N 
4 
4 
6 
10 
16 
6 
8 
26 
4 
15 
12 
16 
45 
79 
249 
operative 
mortality 
M 6 
1/10 
2/16 
1 8 
3 26 
1,4 
1/12 
6 Ί 6 
0 45 
13/79 
29/222 
0 
16.7 
10,0 
12,5 
12,5 
11,5 
25,0 
8,3 
40,0 
0 
16.5 
13,1 
adjuvant 
therapy 
-
pre.i. 
pre i. 
-
-
post 1. 
-
-
-
pre i. 
pre i. 
post.i. 
5-year survival rate 
Actuarial 
" 
62,5 (3 year) 
0 (2 year) 
18,0 
9,0 
Absolute 
0 
0 
0 
0 
0 
0 
18,7 
0 
0 
0 
0 
0 
0 
11.1 
Pre.i = prc-opcrativc irradiation 
Post.i — post-operative irradiation. 
Palva, 1969, performed resection that was expected to be curative in 6 out of 12 
patients who had non-small-cell lung carcinoma with N2 status. The resectability rate 
in this group is 16,7%. All 12 patients died within 2 years. Surgical salvage is negative. 
The exact mediastinal location of lymph node metastases is not indicated. Nor is a 
distinction made between intranodal and perinodal growth of lymph node metastases. 
Gibbons, 1972, resected 10 N2 lung carcinomas. All patients died within a year. 
The average survival rate is 6 months. The operative mortality is 10,0%. Surgical sal­
vage is negative. There are no data on the exact mediastinal location of lymph node 
metastases nor on the intranodal and/or perinodal growth of lymph node metastases. 
Pearson, 1972, selected 32 N2 lung carcinomas that were considered amenable to 
potentially curative resection because of the intranodal growth of lymph node metas­
tases and their ipsilateral, lower paratracheal or tracheobronchial location in the me­
diastinum. They comprise 26 squamous cell carcinomas, 3 anaplastic small-cell carci­
nomas and 3 adenocarcinomas. All patients with small-cell carcinoma and adenocar­
cinoma died within a year after resection. They have not been included in the actuarial 
5-ycar survival rate. Sixteen out of 26 N2 squamous cell carcinomas proved resectable. 
The operative mortality rate in this group is 12,5%. Four of these 16 resected patients 
survived 18, 44, 49, and 50 months respectively, clinically free of tumour. One patient 
survived 20 months after resection, with locally recurrent tumour. All others died as 
a result of tumour metastasis. All patients had pre-operative radiotherapy. The actua­
rial 5-year survival rate is 18,7% (involving exclusively squamous cell carcinomas with 
N2 status). The operative mortality from explorative thoracotomy is not mentioned. 
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If, by way of substitute, the average operative mortality rate of tabic 7-1 is used to 
calculate the surgical salvage, this salvage seems to turn out positive in the case of 
N2 status squamous cell carcinomas with mediastinal lymph node metastases that 
have an exclusively intranodal growth and an ipsilateral, low tracheobronchial loca-
tion This does not apply to lung carcinomas of other histological cell types 
Larsson, 1973, selected 34 patients with N2 carcinoma who underwent potentially 
curative resection All mediastinal lymph node metastases other than ipsilateral ones 
were not considered amenable to surgical treatment Larsson found highly significant 
differences in the survival rates of resected lung carcinomas with ipsilateral N2 status 
and lymph node metastases with intranodal growth, as compared with those with 
perinodal growth Pennodal growth was found in 26 N2 lung carcinomas with lymph 
node metastases having an ipsilateral mediastinal location. All of these 26 patients 
with pennodal, ipsilateral N2 lung carcinoma died within 2 years. The operative mor-
tality rate m the group of pennodal N2 status carcinomas is 11,5"0 The surgical salvage 
is evidently negative On the other hand, intranodal growth was found in 8 lung carci-
nomas with ipsilateral N2 status The actuarial 3-year survival rate in this group of 
lung carcinomas with intranodal, ipsilateral N2 status is 62,5°,,. The operative mortali-
ty rate is 12,50o Surgical salvage in the group of lung carcinomas with intranodal, 
ipsilateral N2 status is positive, but it should be remarked that a 3-year survival rate 
is involved here 
Fosburg, 1974, selected 15 patients for potentially curative resection, from a group 
of 17 N2 lung carcinomas with mediastinal lymph node metastases having only intran-
odal growth and occurring ipsilaterally The selected group comprised 11 squamous 
cell carcinomas, 2 adenocarcinomas and 2 undifferentiated large-cell carcinomas The 
resectability rate is only 26,6";, In only 4 cases potentially curative resection could 
be performed The operative mortality rate is 25,0oo All 3 survivors were post-operati-
vely irradiated, but they died within 2 years The 11 patients from the group of explora-
tive thoracotomies all died within a year Surgical salvage is implicitly negative, in 
spile of the fact that in the evaluation of the operabihty high selection criteria were 
used with respect to the N2 status 
Vnkan, 1974, regards positive results at cervical mediastinoscopy as the principal 
indication that the patient with lung cancer should not be surgically treated. In a group 
of 25 patients with N2 lung carcinoma, 15 patients underwent potentially curative 
resection The average survival after resection was 10,2 months. Only one patient sur-
vived more than 2 years (he died within 3 years after resection) The operative mortality 
after resection is not mentioned, nor is the operative mortality in 10 only explorative 
thoracotomies Surgical salvage is negative I here arc no data on the intranodal or 
pennodal growth of lymph node metastases, nor on their exact mediastinal location. 
Compared with the group of N2 lung carcinomas of table 7-2, the group of carcinomas 
with negative cervical mediastinoscopy has more favourable survival rates 
In the early period 1965-1966, despite mediastinoscopically proven lymph node me-
tastasis Lacquet decided to operate on 13 patients from a group of 72 patients with 
mediastinoscopically proven lymph node metastasis. Of these 13 patients 9 proved 
irresectable, 3 had palliative resection and one had 'curative resection'. There were 
no 5-year survivors. 
Lacquet, 1975, 1976, selected 14 patients with intranodal ipsilateral tracheobron-
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chial mediastinal lymph node metastases At operation, one patient proved irresect-
able, 13 patients resectable Of those 13 there was one false-positive result (wrong 
diagnosis: N1 status) and the patient underwent curative resection, while 12 patients 
underwent palliative resection. In 6 cases lymph node metastases occurred in isolation, 
in another 6 in several locations All lung carcinomas had favourable histology The 
operative mortality rate is 8,3°,,. All 13 resected patients had extended resection and 
no macroscopic tumour was left behind. All patients died within 1 year, the majority 
within 3 months Surgical salvage is negative 
Irlich, 1976, performed thoracotomy in 42 lung carcinomas with N2 status. Only 
16 of them were amenable to curative resection (extended resection) Only 2 of these 
16 patients survived more than a year (they died after 22 and 38 months respectively). 
The first patient had lymph node metastases in the bifurcation, the second had bron­
chopulmonary metastases. Intranodal and'or permodal growth of these lymph node 
metastases is not mentioned Palliative resection was performed in 10 patients The 
remaining 16 proved irrescctable The resectabihty rate is 61,9"0 (26/42) The operative 
mortality rate is 40"
o
. The 5-year survival rate is 0%. Surgical salvage is implicitly 
negative Irlich points out that this series involves mainly well-differentiated carcino­
mas rather than undifferentiated cell type carcinomas 
Kirschncr. 1981, describes 45 patients with N2 lung carcinoma who were resected 
after pre-operative irradiation The mediastinal location of lymph node metastases 
is not mentioned, nor is the intranodal or permodal growth of lymph node metastases. 
The number of adenocarcinomas is remarkably large (31) The resectabihty rate is 
95,7°,, The operative mortality rate is 0"
o
 The actuarial 5-уеаг survival rate is 18%. 
There are 5 long-term survivors ( 5 years), 4 of them have adenocarcinomas Surgical 
salvage is positive 
Pearson, 1982, further differentiated the N2 status in the group of lung carcinomas 
with positive cervical mediastinoscopy. The result was a group of 79 lung carcinomas 
with ipsilaterai lymph node metastases considered amenable to curative resection The 
rescctdbihty rate is 85"¿, the operative mortality rate is 16,500 The actuarial 5-year 
survival late is 9%. The percentage of potentially curative resections is 64,5°,, Surgical 
salvage in this selected group with N2 status is negative There arc no data on the 
intranodal or permodal growth of lymph node metastases Pearson retrospectively 
breaks down the 'curative' resections In this group the actuarial 5-year survival rates 
of squamous cell carcinoma and adenocarcinoma are 18% and 700 respectively In 
the group of N2 lung carcinomas Pearson, 1982, found more favourable survival rates 
for carcinomas where N2 status was established at thoracotomy after negative medias-
tinoscopy. 
VII 3 2 Intranodal and permodal Ivmph node involvemeni in resected lung cancer, N2 
statuì) established at cei vital mediastinoscopy. 
Tables 7-2 and 7-3 show that surgical salvage is negative in virtually all series of 
resected N2 lung carcinomas. 
Bergh, 1965, Pearson, 1972, Larsson, 1973, Fosburg, 1974, Lacquet, 1975, Paulson, 
1976, Smith, 1978, and Pearson, 1982, examined lymph node metastases found at re-
section of N2 lung carcinomas, to determine intranodal or permodal growth and ipsila-
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Table 7-6 Surviial rates of patients with lung carcinomas with mediastinoscopicallv selected N2 status 
who underwent resection. The N2 status is limited to intranodal ipsilatcral lymph node metastasis 
First author Year N2 status 5-year survival Comment 
resected 
N 
Bergh 1965 37 16 37 43,2 2,5-10year 
Pearson 1972 14 3 14 21,4 
Larsson 1973 8 5 8 62,5 3 year survival 
Fosburg 1974 17 0,17 0 
Lacquct 1975 13 0 13 0 
Paulson 1976 12 high sec text 
Smith 1978 55 16 55 29,1 
teral location in the mediastinum. The survival rates are shown in tabic 7-6. 
In a retrospective study Paulson, 1976, found that, out of 13 5-year survivors after 
resection for N2 lung carcinoma (see also table 7-2), in a total of 219 resected N2 
lung tumours, 12 had an N2 status that was limited to intranodal growth and ipsilateral 
location of lymph node metastases at a low mediastinal level, well-differentiated squa-
mous cell carcinomas having a better prognosis. Bergh, Pearson, Larsson and Smith 
all show encouraging survival rates for carcinomas with mediastinal lymph node me-
tastasis that is limited to intranodal growth and ipsilateral location. Fosburg in com-
mon with Lacquet, on the other hand, does not support these findings. The average 
5-year survival rate of this highly selected group of N2 lung carcinomas is 33,3% 
(52/156), and 31,8% (47/148) if the 3-year survival rate of Larsson's series is not in-
cluded. Surgical salvage is implicitly positive in this group of N2 lung carcinomas. 
Pearson's, Lacquet's and Paulson's results involve squamous cell carcinomas. 
VII.4 Summary 
The prognosis of lung carcinoma with mediastinal lymph node metastasis, after 
surgical treatment, is extremely poor. Resection for lung carcinoma is useless unless 
it results in cure. Resection for lung carcinoma with N2 status seldom results in cure. 
Resectability is not equal to curability or operability. The term 'surgical salvage' ex-
presses the per cent difference between the 5-year survival after resection and the opera-
tive mortality at explorative thoracotomy or resection. 19 authors describe their results 
concerning the resection of lung carcinomas with N2 status that was established at 
thoracotomy. The total group comprises 1732 patients. The overall surgical salvage 
is negative. 10 authors describe their results involving the resection of lung carcmomas 
with N2 status that was established at mediastinoscopy. This group comprises 249 
patients. The overall surgical salvage in this group is negative. Surgical salvage appears 
to be positive, however, in the group of patients with lung carcinoma, where nodal 
involvement is limited to intranodal growth and located ipsilaterally in the mediastin-
um at a low tracheobronchial level, and which, preferably, involves squamous cell 
carcinoma. The results are even more favourable in the case of carcinomas where 
the intranodal N2 status was established after negative cervical mediastinoscopy for 
the accessible lymph nodes. In the literature it appears that resection of mediastinal 
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lymph node metastases is pointless unless the metastases are intranodal and their loca­
tion is ipsilateral tracheobronchial Therefore nowadays it would be advisable to oper­
ate patients with a squamous cell carcinoma with mediastinoscopically established 
intranodal lymph node metastasis, ipsilaterally located at lower paralrachcal or tra­
cheobronchial level CT scanning will confirm this status and will give information 
on the possible extent of the lung carcinoma beyond the borders of the lung In order 
to gather these carefully selected patients and to acquire a reliable answer to this ap­
proach a multiccntertnal is needed In this way the patient may benefit from strict 
selectivity in the evaluation of the operabili ty of lung carcinoma with N2 status. 
VII.5 REFERENCES 
1 American Joint Committee on canter In Beahrs OH, Myers MH (Eds) Manual for staging ofcancer 
Lippmcoll, Philadelphia, 1983 
2 AkovbiantzA Die Mediaslmoskopie Hubcr, Bern, 1977 
1 AshrafMH, Milsom PL, Walcsby RK Selection by mediastinoscopy and longterm survival in bronchial 
carcinoma Ann Thorac Surg 40 208, 1980 
4 Barett RJ, Day JC.O'RourkePV, Chapman P I , Sadeghi H Perry RW.TuttlcWM Primary carcinoma 
ofthelung Experience with 1 Inpat ients J Thorac Cardiovasc Surg 46 292 1963 
5 Bcrgh NP Schersten Τ Bronchogenic carcinoma A follow-up study of a surgically treated series with 
special reference to the prognostic significance of lymph node metastases Acta Chir Scand, Suppl 347, 
1965 
6 Bignall JR The course of lung cancer In Bignall JR (Ed) Carcinoma of the lung Livingstone Ldin-
burgh, 1958 p202 
7 Borne J Primary carcinoma of the bronchus Prognosis following surgical resection Ann R Coll Surg 
Lngl 10 165. 1952 
8 Borne J Lung cancer Surgery and survival Applcton-Ccntury-Crofts New York, 1965 
9 Bosch van den JJM, Gelissen HJ, Wagcnaar SS Exploratory thoracotomy in bronchial carcinoma 
J Thorac Cardiovasc Surg 85 733 1983 
10 Boucot K, Cooper D, Weiss W Theroleof surgery in the cure of lung cancer Arch Intern Med 120 168, 
1967 
11 Burford ThH, f-crguson ThB, Spjul HJ Results in the treatment of bronchogenic carcinoma J Thorac 
Surg 36 316, 1958 
12 Carlcns E, Larsson S Mediastinoscopy in lung cancer Sem Rcsp Med 3 176,1982 
13 Coy P, KcnncllyGM The roleofcurative radiotherapy in the treatment of lungcancer Cancer 45 689, 
1980 
14 Preise G, Gabler A, Licbig S Bronchial carcinoma and long-term survival Thorax, 33 228, 1978 
15 Gibbon JHJr AlbrillenFFJr.TcmplctonJYlII, NealonTFJr Cancer of the lung Ann Surg 138 489, 
1953 
16 Ciibbon JH Jr, Stokes TL, Mekcown JJ Jr The surgical treatment of carcinoma of the lung Am J 
Surg 89 484,1955 
17 Gibbons JRP The value of mediastinoscopy in assessing operabihty in carcinoma of the lung Brit 
J Dis Chest 66 162, 1972 
18 HaslcrT Resultate der chirurgischen Therapie beim nicht radikal resezierten Bronchuskar7inom Dis­
sert Zurich, 1966 
19 Iliggings G. Lawton R. Heilbrunn A, Kcehn R Prognostic factors in lung cancer Ann Thorac Surg 
7 472, 1969 
20 Irlich G, Schulte HD, Schappci KD Behandlungscrgebnisse beim Bronthial-karzinom mit histologische 
positivem Befund bei der Mediaslmoskopie Thoraxchirurgie 24 345, 1976 
21 Jenny RH Operative Probleme beim Bronchialkamnom Thoraxchirurgie 10 134 1962 
22 Jenny RH Histologie, Tumorstadium, Lebenserwartung beim Bronchialkarzinom Thoraxchirurgie 
19 244 1971 
23 Jensen HE Exploraliv thoracolomi Dissert Copenhagen 1966 
24 JepsenO Mediastinoscopy Munksgaard Kopenhagen. 1966 
47 
25 Jones J Kern W Chapman N Meyer В Lindesmith G Long-term survival after surgical resection 
for bronchogenic carcinoma J Thorac Cardiovasc Surg 54 484 1967 
26 Kaplan EL Meier Ρ Nonparametnc estimation from incomplete observations J Am Stat Ass 53 457, 
1958 
27 Kirklm JW MacDonald JR Clagctt ОТ Moersch IIJ Gage RP Bronchogenic carcinoma cell type 
and other factors relating to prognosis Surg Gyn Obstet 100 429, 1955 
28 Kirsh MM, KahnDR Gago О Lampe J, I ayos JV Prior M Moores WY Haight С Sloan H Treat 
ment ol bronchogenic carcinoma with mediastinal metastases Ann Thorac Surg 12 11 1971 
29 Kirsh MM Rotman H Argenta L, Bove E Cimmino V Tashian J herguson Ρ Sloan II Carcinoma 
of the lung Results of treatment over ten years Ann Thorac Surg, 21 371 1976 
30 Lacquct A, Wever I dc Corneilhe P, Gruwe/J Le pronostic du cancer bronchique opere Chir 105 492 
1979 
31 Lacquet LK Schaar PJ van der Ervaring met 275 mediastmoscopiccn Acta Chir Belg 64 236 1965 
32 Lacquet LK Schaar PJ van der Resultaten van mcdiastinoscopie Leuvens Τ Geneesk 7 313 1965 
33 Lacquct LK Mcdiastinoscopie bij de opcrabilitcitsbeoordcling van hcl longcarcinoom Τ Geneesk 
6 240 1966 
34 Lacquel LK Schaar PJ van der Mcdiastinoscopie technique et résultais Scalpel 39 3 1966 
15 Lacquet Ι К McrtcnsA KleefJvan JongcnusCM Mediastinoscopy and bronchial carcinoma experi­
ence with 600 mediaslinoscopies Thorax 30 141 1975 
36 Lacquet LK De chirurgische behandeling van hcl longcarcinoom Ned Τ Geneesk 120 228 1976 
37 Lacquet LK La valeur de la mediaslinoscopie dans le traitement chirurgical du cancer pulmonaire 
Ann Chir Thorac Cardiovasc 15 323 1976 
38 Lacquct LK Mertens A Klccf J van Jongenus CM Mediaslinoscopie en longcarcinoom Acta Chir 
Belg 75 187 1976 
39 Lacquet Ι К The value of mediastinoscopy in the assessmenl of iheoperabilily of bronchial carcinoma 
Broncho pneumologie 27 310 1977 
40 Lacquel LK La valeur de la mcdiastinoscopie et de la mediastmotomic dans la selection préopératoire 
des malades avec cancer pulmonaire Rev medí Ierran sciences medie Suppl 32 1978 
41 Larsson S Pretreatment classification and staging ol bronchogenic carcinoma Scand J Thorac Cardio-
vasc Surg Suppl 10 1973 
42 Larsson S Mediastinoscopy in bronchogenic carcinoma Scand J Thorac Cardiovasc Surg Suppl 19, 
1976 
43 Maassen W Ergebnisse und Bedeutung der Mediaslinoskopic und anderer Ihoraxbioplischc Verfahren 
Springer Berlin Heidelberg New York 1967 
44 MarliniN PlehingcrBJ ZamanMB Beatile FJ Prospective study оГ445 lung carcinomas with medias­
tinal lymph node metastases J Thorac Cardiovasc Surg 80 390 1980 
45 Marlini N Hehinger BJ Zaman MB Bealtie CJ Results of resection in non-oat cell carcinoma of 
the lung with mediastinal lymph node metastases Ann Surg 3 386 1983 
46 Naruke Τ Seumasu К Ishikawa S Surgical treatment for lung cancer with metastasis to mediastinal 
lymph nodes J Thorac Cardiovasc Surg 71 279 1976 
47 Naruke Τ Seumasu К Ishikawa S Lymph node mapping and curability at various levels ofmelastasis 
in resected lung cancer J Thorac Cardiovasc Surg 76 832 1978 
48 Nohl HC An investigation into the lymphatic and vascular spread ofcarcinoma of the bronchus Thorax 
II 172, 1956 
49 Nohl НС A three-year follow up of classified cases of bronchogenic carcinoma after resection Thorax 
15 11 I960 
50 Nohl HC I he spread ofcarcinoma of the bronchus Lloyd-I икс london 1962 
51 Nohl-Oser HC The long-term survival of patients with lung cancer treated surgically after selection 
by mediastinoscopv Thorac Cardiovasc Surgeon 28 158 1980 
52 Noordijk FM Classificatie stadiumindeling en radiotherapie van het bronchuscarcinoom Thesis, Um 
versiteli Leiden 1983 
53 OchsnerA Ochsner AJr H Doubler Ch Blalock J Bronchogenic carcinoma DisChest37 1 1960 
54 OchsnerA Lung cancer-Recent advances in diagnosis and treatment Industr Med 38 49 1969 
55 Overholt RH BougasJA Common factors in lung cancer survivors J Thorac Surg 32 508 1956 
56 Overholt RH BougasJA Fnd-rcsults in cancer of the lung Proc Natl Cancer СопГЗ 855, 1957 
57 Overholt RN Neptune WB, Ashraf MM Primary cancer ol the lung Ann Thorac Surg 20 511 1975 
48 
58 PalvaT Viikari S InbcrgM Pulmonary carcinoma Dis Chest 56.2 156 1969 
59 Paulson DL Operability versus resectability in bronchogenic carcinoma Editorial Ann Thorac Surg 
3 177,1967 
60 Paulson DL Carcinoma of the lung Current problems in surgery Yearbook Medical Publisher Inc. 
Chicago, 1967 
61 Paulson DL. Urschel H Selectivity in the surgicallrealment of bronchogenic carcinoma J ThoracCar-
diovasc Surg 62 554, 1971 
62 Paulson DL. Rcisch JS Long-term survival after resection for bronchogenic carcinoma Ann Surg 
184 424 1976 
61 Pearson FG, Nelems JM, Henderson RD. Delarue NC The role of mediastinoscopy in the selection 
of treatment tor bronchial carcinoma with involvement of supenor mediastinal lymph nodes J Thorac 
Cardiovasc Surg 64 382, 1972 
64 Pearson PG, Delarue NC, lives R, Todd TRJ Cooper JD Significance of positive superior mediastinal 
nodes identified at mediastinoscopy in patients with resectable cancer of the lung J Thorac Cardiovasc 
Surg 83 1, 1982 
65 Ramsey HE Cahan WG, Beatile EJ. Humphrey Ch The importance of radical lobectomy in lung 
canter J Thorac Cardiovasc Surg 58 225 1969 
66 Rcyndcrs H Mcdiastinoscopic Academisch proefschrift lJni\ersitcit Amsterdam, 1963 
67 Reyndcrs H Mediastinoscopy in bronchogenic cancer Dis Chest 45 606, 1964 
68 Rubinstein I Baum GL, Kalter Y, Pau¿ner Y, Liebcrman Y. Bubis JJ The influence of cell type and 
lymph node metastases on survival of patients with carcinoma of the lung undergoing thoracotomy 
AmRcvofRcspDis 119 253, 1979 
69 Rubinstein I, Baum GL, Kalter Y, Pauzner Y. Liebcrman Y. Bubis JJ Resectional surgery in the treat 
ment of primary carcinoma of the lung with mediastinal lymph node metastases Thorax 34 33. 1979 
70 Sal/er G Vorschlag einer Finleilung des Bronchuskamnoms nach palhologisch-analomisch-klinischcn 
Gesichtspunkten Wien Med Wochensthr 100 102, 1951 
71 Schaar PJ van der. Zanten M E van Experience with mediastinoscopy Thorax 20 211, 1965 
72 Schaar PJ van der, Lacquct LK Notre experience de la mcdiastinoscopic Ann Chir ThoracCardiovasc 
4 538, 1965 
73 Sensenig DM, Rossi NP. Ehrenhaft JL Results of the surgical treatment of bronchogenic carcinoma 
Surg Gyn Obstet 116 279 1963 
74 Shields ThW. HiggmsG, Kcchn R Factors influencing survival after resection for bronchial carcinoma 
J Thorac Cardiovasc Surg 64 391, 1972 
75 Shields ThW. Yee J. Conn JII, Robinelle CD Relationship of cell type and lymph node metastasis 
to survival after resection of bronchial carcinoma Ann Thorac Surg 20 501 1975 
76 Shields ThW. Kechn RJ Postrcscction stage grouping in carcinoma of the lung Surg Gyn Obstet 
145 725. 1977 
77 Smith RA The results ofraising the resectability rale in operations for lung carcinoma J Thorac Cardio-
vasc Surg 48 418. 1964 
78 Smith RA The importance of mediastinal lymph node invasion by pulmonary carcinoma in selection 
ofpatients for resection Ann Thorac Surg 25 5 1978 
79 S0rensen HR.Thcrkclsen F Treatment of lung cancer Indications and results AclaChirScand 111 239. 
1956 
80 Vnkan SJ, Inbcrg MV Puhakka H. Linna MI Vantinncn E The role of mediastinoscopy in the treat-
ment of lung carcinoma Bull Soc Ini Chir 2 119,1974 
81 Vincent RG.Takila H.Lane WW, Gutierre/AC, PickrenJW Surgical therapy of lung cancer JThorac 
Cardiovasc Surg 71 581, 1976 
82 Watson WL Carcinoma ol the lung with live-year survival J Intern Coll Surg 26 750, 1956 
83 Watson WL Radical surgery for lung cancer Evolution of the operation ol radical pneumonectomy 
and five-year end results Cancer 9 1167 1956 
84 Wilkms EW, Scannell JG, Graver JG Four decades of experience with resections for bronchogenic 
carcinoma at the Massachusetts General Hospital J Thorac Cardiovasc Surg 76 374 1978 
49 
CHAPTER Vil i 
MATERIAL, METHODS, RESULTS 
VIII.l Clinical material 
VIII.J.J Introduction 
In the period 1976-1984 a total of 242 patients with histologically proven lung carci-
noma were studied partly retrospectively, partly prospectively. The 3 separate study 
groups will be indicated by means of the Roman numerals I. II or III: 
I Canisius-Wilhelmina Hospital, Nijmegen - retrospective study 
II Canisius-Wilhelmina Hospital, Nijmegen - prospective study 
HI Lung Centre of Radboud University Hospital, Nijmegen, and Dekkerswald Medi-
cal Centre, Groesbeek - prospective study. 
In the period 1976-1980, 131 patients with demonstrated bronchus carcinoma were 
treated in the Surgery Department of the Canisius-Wilhelmina Hospital. The results 
of cervical mediastinoscopy and/or thoracotomy were studied retrospectively. From 
January 1981 to January 1984 the value of parasternal mediastinoscopy in left-lung 
carcinoma was studied prospectively. In the Canisius-Wilhelmina Hospital cervical 
and parasternal mediastinoscopy were performed in 44 patients with carcinomas 
spreading from the left upper or the left lower lobe. Mediastinoscopy was performed 
in central carcinomas, and in peripheral carcinomas with T2 status. In the same period, 
in the Radboud and Dekkerswald Hospital, the operative results of 67 patients with 
left-lung carcinomas were studied. A prospective study was made of the value of para-
sternal mediastinoscopy in central carcinomas spreading from the left upper lobe. The 
points of division of the segmental bronchi constitute the dividing-line between central-
ly and peripherally located carcinomas. If at fiberoptic endoscopy no visible carcinoma 
was found distal to the points of division of the segmental bronchi, the carcinoma 
was considered peripheral. All carcinomas located proximal to these points of division 
Table 8-1 Study groups and the performed mediastinoscopies. 
I retrospective study (1976-1980) N = 131 (all right-and left-lung carcinomas) 
mediastinoscopy 109 131 
II prospective study (1981-1984) N = 4 4 (left-lung carcinomas) 
mediastinoscopy 37 44 
III prospective study (1981-1984)* N = 67 (left-lungcarcinomas) 
mediastinoscopy 32 67 
total N = 242 178 242 
* The results of left parasternal mediastinotomy before this period are not included in the present senes 
(Lacquet 1978) 
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were considered central. In both the retrospective and the prospective studies the histo­
logical diagnoses of all patients were verified and confirmed by the same pathologist. 
Table 8-1. shows the numbers of patients with bronchus carcinoma in each study 
group and the performed mediastinoscopies. 
The retrospective study group (I) comprises 131 patients with lung carcinoma in 
the left or right lung. The prospective study groups (II + III) comprise 111 patients 
with left-lung carcinoma. 
VIH.1.2 Age-distribution. 
Table 8-2 shows the age-distribution of all patients in the 3 study groups (n = 242). 
Table 8-2. Age-distribution of all 242 patients at mediastinoscopy and 'or thoracotomy 
100-
5 0 -
108 44 6% 
72 29 8% 
13 5 4 % 
0 8% 
47 19 4% 
η -- 242 30 40 50 60 70 80 
74.4°'
a
 of patients fall into the age-group 50-70. The youngest patient was 32 years 
old, the oldest was 79. Table 8-3 shows the age-distribution in each of the separate 
study groups. Differences between the groups are minor. 
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Tabic 8-3 Age-distribution at mediastinoscopy and or thoracotomy in the separate study groups 
60 
5 0 -
g 40-1 
σ 
2 30 
2 0 -
10 
0 8% 
5 3% 
59 45 0% 
39 29 8% 
25 19 1 % 
n - 1 3 1 30 40 50 60 70 80 
18 40 9% 
η - 6 7 
VIH. 1.3 Sex-distribulion. 
7,9% of all patients with lung carcinoma are women. Table 8-4 shows the sex-distn-
bution in the study groups. 
In 1982 the man-woman ratio in the prevalence of lung carcinoma in the Netherlands 
was 10:1 (Peeters 1985). In present scries the man-woman ratio is 11,7:1. 
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I able 8-4 Sex distribution 
HI Total 
Men 124 94.7 41 93,2 58 86,6 223 92 1 
Women 7 5,3 3 6,8 9 13 4 19 7,9 
131 44 67 242 
VIIII 4 Location of the primary tumour 
Table 8-5 shows the location of the primary tumour in the 242 patients In group 
I 55,7% of patients have right-lung carcinomas (n = 73) 
Table 8-5 Location of primary tumour according to lobe 
L U L * 
N "„ 
I 38 29,0 
II 29 65,9 
III 41 61 2 
L L L 
Ν ",, 
20 15.3 
13 29.5 
21 31 3 
R U L 
Ν "„ 
38 29,0 
R M L 
Ν "„ 
6 4,6 
R U / 
M L -
N '„ 
1 0,8 
R L L 
N 0„ 
25 19,1 
R M / 
L L 
N "„ 
3 2,3 
L U / 
L L 
N "„ 
2 4,5 
3 4,5 
Left 
Main 
bronchus 
Ν "„ 
2 3,0 
Ν - 242 
* L U L = left upper lobe 
L L L - left lower lobe 
R U L = right upper lobe 
R M L = right middle lobe 
R U M L — right upper middle lobe 
R L L = right lower lobe 
R M 'I I = right middle lower lobe 
I U /L L = left upper/lower lobe 
The group of carcinomas which are centrally located make up a majority of 59,1% 
Table 8-6 shows the distribution of central and peripheral carcinomas in each of the 
study groups 
Table 8-6 Location of tumour, central vs peripheral 
I 11 
N 0„ N О 
о 
III 
N О 
о 
Total 
Ν 
О 
Central 81 61,8 26 59 1 36 53,7 143 59 1 
Peripheral 50 38.2 18 40,9 31 46 3 99 40 9 
131 100 44 100 67 100 242 100 
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Vili 1 5 Histolog\ ojthepiimary tumour,acLoidmgto WHO, 1982 
Table 8-7 shows the distribution of the various histological cell types in all study 
groups Table 8-8 shows the distribution of the histological cell types in each study 
group 
Table 8-7 Histology of the tumour m a total of 242 patients (for numbering groups sec table 8-K) 
169 69 8% 
150 -
100-
50 -, 
30 12 4% 
21 8 7% 
8 3 3% 7 2 9% 
[2 0 8% τ 0 4%i 0 4%; 
5 6 7 8 9 
3 1 2% 
Squamous cell carcinoma comes first, comprising 69,8"0, followed by adenocarcino­
ma, comprising 12,4"0 The undifferentiated small-cell carcinomas and undifferentiat­
ed large-cell carcinomas make up 11,6"0 of the total number The various histological 
cell types are evenly distributed among the 3 study groups 
VIII.2 Cervical and parasternal mediastinoscopy 
VII 12 I Methods of nnesttgatton 
The technique of cervical mediastinoscopy was used basically as described by Car-
lens, 1959 Many authors, eg Reynders, 1963, Palva, 1964, Pearson, 1965, Jepsen, 
1966, Maassen 1967, Sarrazin 1968. Akovbiant/, 1977 described this technique in a 
similar way The examinations were performed under general intubation anesthesia 
No other modifications ofCarlens' method (Specht, 1965) were tried The technique 
of parasternal mediastinoscopy is described in Chapter V and as such closely related 
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Table 8-8 Histology cell group of lung carcinomas in the separate slud> groups, η = 242 
100-1 
Î 1 
5 0 -
n = 131 
30-
n = 44 
4 0 -
m 
η = 67 1 2 3 4 5 6 7 8 9 
1 = squamous cell carcinoma 
2 = adenocarcinoma 
3 = bronchio-alveolar carcinoma 
4 = undifferentiated small-cell carcinoma 
5 = undifferentiated large-cell carcinoma 
6 = combination ofsquamous cell and undifferentiated small-cell carcinoma 
7 = carcinoid tumour 
8 = malignant fibrous histiocytoma 
9 = unspecified carcinoma 
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to the technique described by Jolly, 1980 and Page, 1980 An other method of biopsy 
of mediastinal structures (Brouet, 1958, Stemmer, 1965, McNeill, 1966, Nordenstrom. 
1967), namely left parasternal mediastinotomy, was performed in the Radboud and 
Dekkcrswald Hospital before 1981 (Lacquet, 1977, 1978) These patients are not in-
cluded in the present series Specimens were taken from all visible lymph node stations, 
and collected in different containers, the source was recorded in order to ensure that 
after histological examination the exact location would be assigned to any metastases 
that were found In order to examine whether a metastasis showed intranodal or pen-
nodal growth, lymph node specimens with surrounding fat were taken as biopsies 
for histological examination. 
VIII2 2 Results of cervical and parasternal mediastinoscopy. 
Cervical and parasternal mediastinoscopy were performed to determine the operabi-
hty of the bronchus carcinoma The numbers of patients in study groups I, II and 
HI who underwent cervical and/or parasternal mediastinoscopy are 109, 37 and 32 
respectively (table 8-1), making up a total of 178 patients. In group I only cervical 
mediastinoscopy was performed In group II cervical and parasternal mediastinoscopy 
were performed in all patients with central left lung carcinomas Cervical and/or para-
sternal mediastinoscopy were performed in peripheral lung carcinomas only if it con-
cerned a T2 tumour with or without suspicion of mediastinal metastasis on the x-ray, 
or if it concerned an undifferentiated carcinoma In group III cervical and parasternal 
mediastinoscopy were performed in central left upper lobe tumours only, or on a selec-
tive basis in T2 peripheral left upper lobe tumours The results of cervical mediastinos-
copy in group I were also studied with respect to right-lung carcinomas These are 
shown in table 8-9 and broken down according to central or peripheral location and 
according to lobe The percentage of positive cervical mediastinoscopy in central right-
lung tumours was 23,4\ (11/47) One patient did not undergo mediastinoscopy be-
cause of kyphosis The percentage of positive cervical mediastinoscopy in the selected 
peripheral right-lung tumours was 26,7% (4/15) The results in the case of left-lung 
tumours are broken down according to central or peripheral location and according 
to lobe The results of cervical and parasternal cervical mediastinoscopy are shown 
in tables 8-10 and 8-11, broken down for each study group In the retrospective study 
group the percentage of positive cervical mediastinoscopy is 15,8% in central tumours 
spreading from the left upper lobe and 50/o in those spreading from the left lower 
lobe 
In all study groups together, the percentage of positive cervical mediastinoscopy 
is 22,2"() (12 54) in tumours spreading from the left upper lobe and 46,7% (14/30) 
in those spreading from the left lower lobe 
In the retrospective study group the percentage of positive cervical mediastinosco-
pies involving the left upper lobe is distinctly lower than that of mediastinoscopies 
involving the right lung The literature supports this finding (table 8-12). All authors 
report a higher yield after cervical mediastinoscopy in right-sided lung carcinomas 
than in left-sided lung carcinomas Jepscn, Maasscn, Sarra/in, Akovbiantz and Rouk-
ema find a significantly lower yield after cervical mediastinoscopy in the left upper 
lobe in particular. This is caused by the fact that the lymphatic drainage of the left 
56 
Table 8-9. Righl-sided lung carcinomas with positive cervical mediastinoscopy in group I, 15 62 (lymph 
node metastasis established at cervical mediastinoscopy) and those which had no mediastinoscopy, 11.73. 
N = 73 
Central hi ation RU.L.* R.M L R.U./M. L.R.LI. R M . L L. Right lung 
Mediastinoscopy 5 20 
No mediastinoscopy 
Total 20 
Peripheral location 
1/6 0 I 3/18 22 
I 3 
18 
11,47 23,4 
48 
Mediastinoscopy 4 11 
No mediastinoscopy 7-18 
Total 18 
0,4 
3,7 
4,15 26,7 
25 
R.U L. = right upper lobe 
R.M.L. = right middle lobe 
R.U. M L. = right upper middle lobe 
R L L. = right lower lobe 
R.M./L.L. = right middle, lower lobe 
lung, and of the left upper lobe in particular, passes through the peri-aortic lymph 
node stations, which are inaccessible during cervical mediastinoscopy. In the clinical 
field this is confirmed by Roukema, Deneffe, Smith, Pearson, Murray, Gardner, Page, 
and Schreinemakers. In lung carcinomas spreading from the left upper lobe, all of 
them found peri-aortic lymph node metastases at thoracotomy after negative cervical 
mediastinoscopy (table 8-13). The percentage of peri-aortic lymph node metastases 
found after negative cervical mediastinoscopy varies, in the literature, from 7,7% to 
83,3%, with an average of 23,0% (64/278). 
At parasternal mediastinotomy or mediastinoscopy after negative cervical medias-
tinoscopy. Pot, Bowen, Deneffe, Lacquet, 1978, and Smith (table 8-13) found, in carci-
nomas spreading from the left upper lobe, lymph node metastases in 23,5% - 46,2% 
of cases with an average of 32,3% (54/167). 
Evans in common with Page performed parasternal exploration without preceding 
cervical mediastinoscopy, and both report a high yield (table 8-13), 84,3 and 54,8%. 
Left-lung carcinomas in study groups II and III were studied prospectively. In group 
III the central left-upper-lobe carcinomas were first examined by means of cervical 
mediastinoscopy. The material obtained was submitted to the pathologist for frozen-
section-slide examination. When the results proved negative, parasternal mediastinos-
copy was performed subsequently, and the material obtained was sent off for paraffin-
scction-slide examination. The outcome constituted the extra yield of parasternal me-
diastinoscopy. Parasternal mediastinoscopy was not performed in left lower lobe carci-
nomas. 
In group II cervical and parasternal mediastinoscopy were performed in all central 
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Table 8-10 I.eft-sided central lung carcinomas with positive cervical mediastinoscopy; those with positive 
parasternal mediastinoscopy after negative cervical mediastinoscopy, and those which had no mediastino­
scopy. According to lobe N = 95 
Left upper lobe 
Cervical mediastinoscopy 
Extra yield of parasternal 
mediastinoscopy 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 
Left lower lobe 
Cervical mediastinoscopy 
Extra yield of parasternal 
mediastinoscopy 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 
Left upper'lower lobe 
Cervical mediastinoscopy 
Extra yield of parasternal 
mediastinoscopy 
I 
3/19 
7/14 
15,8 
50,0 
II 
4/18 
3/14 
7,18 
3/7 
1/4 
4/7 
0/1 
O'l 
0 / 
22,2 
21.4 
38,9 
42,9 
III 
5/17 
2/12 
7 Ί 7 
3/20 
4/9 
4/13 
1/1 
l> 
29,4 
16,7 
41.2 
15,0 
44,4 
30,8 
Total 
12/54 
5/26 
14/35 
3,20 
14'30 
1,4 
4/7 
4,13 
0/1 
1/2 
"/a 
22,2 
19,2 
40,0 
15,0 
46,7 
30,8 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 
Main bronchus 
Cervical mediastinoscopy 1/1 1,1 
Extra yield ofparasternal 
mediastinoscopy 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 1/2 1/2 
carcinomas in both upper and lower lobes. The same procedure was followed in the 
selected group of peripheral left-lung carcinomas. To make it possible to compare 
both study groups, the same procedure that was followed in group HI was worked 
out for group II as well. The results are shown in tables 8-10 and 8-11. Table 8-10 
shows the results of cervical and parasternal mediastinoscopy in the separate study 
groups, broken down according to lung lobe. Cervical mediastinoscopy, in central 
lung carcinomas, involving the left upper lobe yields a low percentage of positive cases: 
15,8%, 22,2% and 29,4% for study groups I, II and III respectively. Combined with 
parasternal mediastinoscopy the percentages of positive cases in groups II and III 
are 38,9% and 41,2% respectively. 
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Table 8-11 Left-sided peripheral lung carcinomas with positive cervical mediastinoscopy, those with posi­
tive parasternal mediastinoscopy after negative cervical mediastinoscopy, and those which had no medias­
tinoscopy According to lobe N = 74 
Left upper lobe 
Cervical mediastinoscopy 
Extra yield of parasternal 
mediastinoscopy 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 
Left lower lobe 
Cervical mediastinoscopy 
Extra yield of parasternal 
mediastinoscopy 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 
Left upper'lower lobe 
Cervical mediastinoscopy 
Extra yield of parasternal 
mediastinoscopy 
Cervical and parasternal 
mediastinoscopy 
No mediastinoscopy 
I 
1Ί2 
7/19 
0/2 
4/6 
% 
8,3 
36,4 
II 
3/8 
1,5 
4,8 
3Ί1 
0,2 
0/2 
0/2 
4/6 
0/1 
0/1 
0,1 
% 
37,5 
20,0 
50,0 
27,3 
III 
/o 
21'21 100 
0/3 
5/8 
0/1 
1,2 
Total 
3/20 
1/5 
4/8 
31,51 
0/7 
0/2 
0/2 
13/20 
0/2 
0/1 
0/1 
1/2 
% 
15,0 
20,0 
50,0 
60,8 
65,0 
In the case of left lower lobe carcinomas, parasternal mediastinoscopy was per­
formed in group II only. 
The extra yield of parasternal mediastinoscopy in central lung carcinomas was 5/26 
= 19,2% in left upper lobe carcinomas (groups II and III), and 1/4 in left lower lobe 
carcinomas (group II). 
In peripheral left-lung carcinomas (group II), table 8-11, the extra yield of paraster­
nal mediastinoscopy was 1/5 = 20,0% in left upper lobe carcinomas. Parasternal me­
diastinoscopy was never positive in peripheral left lower lobe carcinomas. 
In table 8-14 the positive cervical and/or parasternal mediastinoscopies are assigned 
to the various histological types of lung carcinoma. Table 8-14 concerns centrally locat­
ed carcinomas. Compared with the retrospective study group I, the yield of combined 
cervical and parasternal mediastinoscopy in the prospective study groups II and III 
has doubled in both groups where squamous cell carcinomas are concerned. 
In the group of central lung carcinomas, the adenocarcinomas and small-cell carci­
nomas comprise only 20 patients. The average yield at cervical and/or parasternal 
mediastinoscopy is 60% ( 12/20). 
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I able 8-12 The yield at cervical mcdidSlinoscop> of positive lymph nodes m the right vs left lung I he 
yield in the left upper lobe is mentioned separately 
First author 
Maassen 
Jepsen 
Maassen 
Sarrazin 
Gunstcnsen 
Jolly 
Palva 
Goldberg 
Lacquct* 
Akovbmntz 
Roukema 
Present scries , retrospective part 
Study group I (N = 109) 
Year 
1964 
1966 
1967,1971 
1971 
1972 
1973 
1973 
1974 
1976 
1977 
1983 
1985 
Number cervical 
right lung 
0 
26 67 
67 163 
142 366 
43 93 
29 95 
35 86 
83 186 
57 108 
95 243 
25 83 
15 62 
38.9 
41,1 
38,8 
46,2 
30,5 
40,7 
44,6 
52,8 
81,0 
39,1 
30.1 
24,2 
1 mediastinoscopy posilivc 
left lung 
0 
17 73 23 3 
49 162 30.2 
99/309 32,0 
38 99 38,4 
14/82 17,1 
15 68 22,1 
76 170 44,7 
29 71 40,8 
59,0 
49 143 34.3 
16/87 18.4 
11 47 23,4 
Left Upper Lobe 
0 
14 55 
26 97 
103 381 
22 61 
12 50 
43 86 
20 48 
26 79 
1261 
3 19 
25,5 
26,8 
27,0 
36,1 
24.0 
50,0 
41,7 
63,0 
32.9 
19,7 
15,8 
* percenldgcs of positive biopsies (lymph node metastasis established) with paralrachcal and tracheobron-
chial location in a total of 246 positive biopsies 
In the group of peripheral lung carcinomas, the distribution of cell types is different 
(tabic 8-15). 
In this selected patient group the percentages of positive cervical and/or parasternal 
mediastinoscopies involving squamous cell carcinoma, adenocarcinoma and small-cell 
anaplastic carcinoma are 30,0/,,, 33,3% and 16,7% respectively 
If cervical and/or parasternal mediastinoscopy had been performed in all peripheral 
lung carcinomas and the positive mediastinal lymph nodes, accessible at cervical and/ 
or parasternal mediastinoscopy and found at thoracotomy, had been taken into ac-
count, the hypothetical yield in the peripheral lung carcinomas of all 3 groups would 
have been 15,2% for squamous cell carcinoma, 16,7% for adenocarcinoma and 30% 
for small-cell anaplastic carcinoma. These rates seem to justify cervical and/or para-
sternal mediastinoscopy in the case of peripheral T2 lung carcinoma (table 8-16), and 
we act accordingly in selected cases 
The yield of cervical mediastinoscopy in peripheral T2 lung carcinomas amounts 
to about half the yield of cervical mediastinoscopy in central lung carcinomas This 
finding is supported by Specht, 1963, Jepsen, 1966, Rink, 1970, Doctor, 1971, Maas-
sen, 1971, Greschuchna, 1973, Baker, 1975 and Hutchinson, 1976 
VIII2 3 Intranodal and pennodal growth oj lymph node metastases found at cervical 
or parasternal mediastinoscopy 
40,7% of positive cervical and/or parasternal mediastinoscopies involved intranodal 
lymph node metastases, while nearly 60% involved pennodal lymph node metastases 
(table 8-17). 
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Table 8-13 Numbers of left-sided N2 lung carcinomas with aortic lymph node involvement, found at para­
sternal mediastinolomy,bcopy or at thoracotomy, after negative cervical mediastinoscopy or no cervical 
mediastinoscopy 
First author 
Evans 
Murray 
Gardner 
Bowen 
Lacquct 
Page 
Page 
Deneffe 
DenelTe 
Pearson 
Smith 
Smith 
Deneffe 
Pot 
Roukema 
Present series 
Retrospective part 
Prospective part 
Year 
1973 
1975 
1976 
1978 
1978 
1980 
1980 
1982 
1982 
1982 
1982 
1982 
1983 
1983 
1983 
1985 
Parasternal 
mcdidstinolomy/ 
scopy 
43/51 
10/28 
2/8 
23/42** 
4/16 
10/26 
6/Π 
18/59 
4/17 
8/40** 
О 
84.3 
35,7* 
25,0* 
54,8 
25,0* 
38,5'* 
46,2* 
30,5* 
23,5* 
-
20,0 
Thoracotomy 
о 
6/12 50,0 
5/6 83,3* 
10/29 34,5 
23/100 23.0* 
1/13 7.7 (MT-) 
7/6) 11,5 (MT-) 
12/39 30,8* 
10/47 21,38 
Cervical 
mediasti­
noscopy 
performed 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
1
 Radiological evidence of mediastinal enlargement 
* Left Upper Lobe. 
** Parasternal mediastinoscopy 
MT- negative left parasternal mcdiastmotomy (no lymph nodes were found to be metastatically involved) 
Table 8-14 Central lung carcinomas with positive cervical and'or parasternal mediastinoscopy, and those 
which had no mediastinoscopy, according to histological group. 
Ill 
MS 
no MS 
MS 
no MS 
MS 
no MS 
MS 
no MS 
о 
η 
15,70 21,4 
2/5 
3/6 
1/2 
О 
10/24 41,7 
1/1 
о/ 
о 
11'25 44.0 
4 29 13.8 
1/1 
1/1 
3/4 
Squamous cell 
carcinoma 
Adenocarcinoma 
Small-cell 
carcinoma 
Small-cell 
+ squamous 
cell carcinoma 
MS = positive cervical and'or parasternal mediastinoscopy 
no MS = no mediaslmoscopv performed 
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Table 8-15. Peripheral lung carcinomas with positive cervical and/or parasternal mediastinoscopy, and 
those which had no mediastinoscopy, according to histological group. 
Ι Π III I + II + III 
% 
Squamous cell MS 
carcinoma no MS 
Adenocarcinoma MS 
no MS 
Small-cell MS 
carcinoma no MS 
MS = cervical and/or parasternal mediastinoscopy 
no MS = no mediastinoscopy performed 
Table 8-16. Hypothetical numbers of peripheral lung carcinomas with N2-status established at cervical 
and parasternal mediastinoscopy, according to histological cell group. All carcinomas included 
I II III I + II + III 
% 
Squamous cell MS 4/27 3/8 0/11 7/46 15,2 
carcinoma 
Adenocarcinoma MS 0/7 2/5 2 12 4/24 16,7 
Small-cell MS 1/5 0/2 2/3 3/10 30,0 
carcinoma 
MS = cervical and/or parasternal mediastinoscopy. 
Table 8-17 Intranodal or pcnnodal growth of lymph node metastases. 
I 
II 
III 
Total 
intranodal 
N 
12 
6 
4 
22 
0 / 
40,7 
pennodal 
N 
14 
9 
5 
28 
% 
51,9 
intranodal and 
pennodal 
N 
4 
4 
% 
7,4 
Total 
26 
15 
13 
54 
All biopsy specimens were examined by the same pathologist. The higher yield of 
perinodal metastases in group IH can be explained by the fact that larger biopsy speci­
mens were taken, invariably including lymph node capsules and surrounding medias­
tinal fatty tissue. 
Bergh, 1965, was the first to point out the importance of intranodal or perinodal 
4; 13 
14/27 
0'3 
4,7 
1/4 
1/5 
2 6 
2/8 
2/2 
3'5 
0,2 
0/1 
10/11 
0/1 
11/12 
3/3 
6/20 
26'46 
2/6 
18 24 
1 6 
4/8 
JU,U 
56.5 
33,3 
75,0 
16,7 
50,0 
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growth. Pearson 1972, Larsson, 1973 and 1976, and Carlens, 1982, support this. In 
resected N2 lung carcinomas where nodal involvement is limited to intranodal growth, 
the 5-year survival rale is about 30%. 
If one of our patients had positive results at cervical and/or parasternal mediastino­
scopy, he was considered surgically incurable and no thoracotomy was performed.* 
VIII.2.4 The location of lymph node metastases in the mediastinum. 
A distinction was made between ipsilateral and contralateral location, and the carina 
is mentioned if it is positive (table 8-18). In the retrospective study group the exact 
location of the lymph node metastases could not be traced in 5 cases. In the prospective 
study group the data on the exact location of metastases of one patient were lost. 
The percentage of contralateral and bilateral lymph node metastases is 18,5%. In the 
literature this percentage varies from 12,5% to 33% (Jepsen, 1966, Doctor, 1971, Palva, 
1973, Carlens, 1974, Fosburg, 1974, Preise, 1974, Akovbiantz, 1977). 
Tabic 8-18 Location of mediastinal lymph node metastases found at cervical and/or parasternal mediasti­
noscopy 
Ipsilateral 
Contralateral 
Ipsi + Contralateral 
Canna 
Ipsi + Contralateral + Canna 
Ipsilateral + Carina 
Unknown 
Total 
1 
N 
18 
3 
5 
II 
N 
10 
4 
1 
in 
N 
6 
2 
2 
1 
1 
1 
I + II + III 
N % 
34 63,0 
2 3,7 
7 13,0 
2 3,7 
1 1,9 
2 3,7 
6 11,1 
26 15 13 54 
Of the 242 patients, 178 underwent cervical and/or parasternal mediastinoscopy 
and 54 of them proved to have metastatically involved lymph nodes in the mediasti­
num. They were not considered amenable to thoracotomy. Two patients were rejected 
for thoracotomy on cardiac grounds, 2 patients proved to have distant metastases, 
2 patients refused to be operated. 
Ш.2.5 Complications at parasternal mediastinoscopy 
In present series of parasternal mediastinoscopies 7 complications were observed: 
3 minor hemorrhages, which could easily be staunched with gauze packs 
1 wound infection 
1 partial pneumothorax, which did not necessitate suction drainage 
* positive mediastinoscopy lymph node metastases found at mediastinoscopy 
negative mediastinoscopy, no lymph node metastases found at mediastinoscopy. 
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1 paresis of the left recurrent nerve 
1 paresis of the left phrenic nerve 
VIII.3 Results of thoracotomy 
VIII.3.1 Resectability rates 
Thoracotomy was performed in 184 patients. The resectability rates were 80,8% 
in the retrospective group, and 86,7% and 96,4% in the prospective groups II and 
III respectively (see: addendum 1). 
Study group 
only explorative thoracotomy 
I 
0 
19,99 19,2 
II 
4-30 
•Ό 
13,3 
III 
2 55 
% 
3.6 
The percentage of patients who had only explorative thoracotomy was 25/184 = 
13,6%. This rate corresponds with the results of other studies where mediastinoscopy 
was performed in the pre-operative selection for the evaluation of the operability of 
lung carcinoma (see: Chapter VII). 
VIII.3.2 Peri-aortic lymph node metastases found at thoracotomy. 
At thoracotomy after negative cervical mediastinoscopy, peri-aortic lymph node 
metastases were found in 10 patients with left-sided lung carcinoma in study group 
I. One patient had thoracotomy after positive cervical mediastinoscopy, table 8-19. 
This involved 8 patients with carcinomas spreading from the left upper lobe, and 6 
patients with central carcinomas. 
Tabic 8-19 Pen-aortic lymph node metastases found at thoracotomy after negative cervical mediaslino-
scopy m group I (no parasternal mediastinoscopy was performed), π = 47 
histological cell type of the carcinoma 
location of carcinoma 
squamous adeno- undifferentiated unspecified 
cell carcinoma small-cell carcinoma 
carcinoma carcinoma 
central L.U.L * 4 1 
peripheral L.U.L 2 I 
central L L L 1 
peripheral L L L. 1 
* L U L. = left upper lobe 
L L L = left lower lobe 
The total number of left-lung carcinomas in group I is 58. 
In 11 patients with left lung carcinomas, lymph node metastasis was found at cervical 
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Ν 
20 
19 
3 
6 
21 
4 
4 
3 
0 
0 
25.0 
23,7 
3,7 
7,5 
26,2 
5,0 
5,0 
3,7 
Ν 
1 
10 
6 
1 
2 
3 
2 
Ι 
% 
3,8 
38,5 
23.1 
3,8 
7,7 
11,5 
7,7 
3,8 
Ν 
Π 
10 
5 
2 
11 
3 
4 
3 
4 
Ο 
•Ό 
20.8 
18,9 
9,4 
3,8 
20,8 
5,7 
7,5 
5.7 
7,5 
Ν 
1 
41 
35 
9 
10 
35 
9 
4 
8 
7 
Ο 
0 
0.6 
25.8 
22.0 
5,7 
6,3 
22,0 
5,7 
2,5 
5,0 
4,4 
Table 8-20. Post-operative TN M-stagmg of resected patients in each of the study groups. M = 0. 
1 II III I + II + III 
TONO 
T I N O 
T2NO 
T3NO 
Tl N1 
T2N1 
T3N1 
Tl N2 
T2N2 
T3N2 
Total 80 100 26 100 53 100 159 100 
mediastinoscopy (11/47 = 23,4%) in group I (table 8-12). They were not considered 
amenable to thoracotomy. (One patient with a central adenocarcinoma spreading 
from the left lower lobe did have the operation; in this case, too, peri-aortic lymph 
node metastases were detected per- operatively.) At thoracotomy after negative cervi­
cal mediastinoscopy, peri-aortic lymph node metastases were found in 9 of the remain­
ing 36 patients. 
If both cervical and parasternal mediastinoscopy had been performed, the total yield 
of positive mediastinoscopies would have been 42,6% (20/47), assuming none of the 
parasternal mediastinoscopies would have been false- negative. 
Virtually all positive mediastinal peri-aortic lymph nodes were extensions of primary 
carcinomas in the left upper lobe (8/9). 
In 8 patients in the prospective study groups peri-aortic lymph node metastases 
were found pcr-opcratively too. In study group II this involved 2 patients with peri­
pheral carcinomas. In one patient no cervical or parasternal mediastinoscopy was per­
formed (peripheral left upper lobe). In one patient with peripheral squamous cell carci­
noma spreading from the left upper lobe,both cervical and parasternal mediastino­
scopy were performed, and both were negative. In this case, therefore, the results of 
parasternal mediastinoscopy were truly false-negative. The results of parasternal me­
diastinoscopy in central carcinomas were never false-negative. In study group II 19 
patients with central lung carcinomas had parasternal mediastinoscopy after negative 
cervical mediastinoscopy. The results were positive in 21% (4/19) of them. In one case 
the results of parasternal mediastinoscopy were false-negative. In 5 peripheral lung 
carcinomas in study group III peri-aortic lymph node metastases were found. Three 
of them were adenocarcinomas, one was a squamous cell carcinoma and one a small-
cell carcinoma. In 3 cases the primary carcinoma was located in the left upper lobe, 
in 2 in the left lower lobe. 
In the central carcinomas only 1 false-negative parasternal mediastinoscopy was 
observed, involving a squamous-cell carcinoma spreading from the left upper lobe. 
In study group III 13 patients with central carcinomas had parasternal mediastino-
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Table 8-21 Early mortality, according to TNM-classification, and cases ofonly explorative thoracotomy 
ON 
TONO TINO T2N0 T3N0 TINI T2N1 T3N1 T1N2 T2N2 T3N2 Explorative Total 
thoracotomy 
I 
11 
III 
1+11 + H I 
0/1 
o/i 
% 
1/20 
0/10 
0/11 
1/412,4 
% 
2/19 
0/6 
0/10 
2/35 5,7 
% 
1/3 
0/1 
0/5 
1/9 11,1 
% 
1/6 
0/2 
1/2 
2/10 20,0 
% 
2/21 
0/3 
0/11 
2/35 5,8 
% 
3.4 
1/2 
0/3 
4/9 44,4 
0/4 
0/4 
% 
1/4 
ι/ι 
1/3 
3/8 42,8 
% 
1/3 
0/4 
1/7 14,2 
/o 
1/19 
0/4 
0/2 
1/25 4,0 
û/ 
13/99 13,1 
2/30 6,7 
2/55 3,6 
17/184 9,2 
scopy after negative cervical mediastinoscopy In 25,0% (3/12) of them results were 
positive. In only one case the results of parasternal mediastinoscopy were false-nega­
tive 
VIII.3.3.1 Rates of survival after resection, pTNM staging according to the TN M sys­
tem 
A total of 184 thoracotomies were performed 159 patients were resected. These 
patients were staged post-operatively, according to the TNM system (table 8-20) 
VIII.3 3.2 Early mortality 
In table 8-21, early mortality is calculated according to TNM. 
In stage I lung carcinomas early mortality is 5,7% (5/87) including the early mortality 
of the TN combinations TONO 0% (0/1), TINO 2,4% (1/41), T2N0 5,7% (2/35) and 
TINI 20%(2/10). 
In stage II lung carcinomas early mortality is 5,7% (2/35), including the TN combi­
nation T2N1 5,7% (2/35), 
In stage III lung carcinomas early mortality is 24,3% (9/37) including the TN combi­
nations T3 N0 11,1% (1/9), T3N1 44,4% (4/9), T1N2 0% (0/4), T2N2 42,8% (3/8) 
and T3N2 14,2% (1/7). 
Early mortality is almost equal in stage I and stage II lung carcinomas: 5,7% (5/87) 
in stage I and 5,7% (2/35) in stage II respectively, but increases significantly in stage 
III lung carcinomas 24,3% (9/37) 
Early mortality is significantly worse in stage III lung carcinomas The difference 
in early mortality between stage 1 and stage III is statistically significant according 
to the chi-square probe (p = 0,007). The difference in early mortality between stage 
II and stage III is almost statistically significant according to the chi-square probe 
(P = 0,06) 
Since the stage of the tumour is defined by the combination of the Τ and N variables 
(M is invariably M0 in this series), it is interesting to look in detail at the separate 
variables 
In the Τ variables, early mortality in the T0-1 group lung carcinomas is 5,4% (3/56), 
in the T2 group 9,0% (7/78) and in the T3 group 24,0% (6/25). 
In the N variables, early mortality in the N0 group lung carcinomas is 4,7% (4/86), 
in the N1 group 14,8% (8,54) and in the N2 group 21,1% (4/19). 
It seems that early mortality is related to the combination of Τ an N variables. 
The highest Τ variable with the lowest N variable shows relatively low early mortality 
(T3N0 early mortality 11,1% (1/9)) as does the lowest Τ variable with the highest 
N variable (T1N2 early mortality 0% 0/4) In evaluating the operability of stage III 
lung carcinomas the combination of Τ and N variables must be considered, in order 
to avoid a strong increase in early mortality. 
VIII3 3 3 Survival curves, according to stage-classification 
The survival is expressed in terms of days In stage-I carcinomas the median survival 
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is 1575 days (4,3 years). In stage-II carcinomas the median survival is 420 days (1,2 
years). In stage-Ill carcinomas the median survival is 230 days (0.6 year). Survival 
was measured by the Kaplan Meier method, including early mortality and deaths from 
lung cancer, excluding deaths from unrelated causes, excluding loss of follow up. 
The survival curves of stage I and stage II are significantly different, according to 
the logrank test (p = 0,0003). The survival curves of stage II and stage III are signifi­
cantly different, too, according to the logrank test (p = 0,015). 
According to the logrank test there is a tendency to statistical significance in the 
differences in survival between resected T3N0 and T3N2 combinations (p =0,08) 
whereas there is not in the differences in survival between T3N0 and T3N1 combina­
tions of lung carcinomas (p = 0,4).The survival curves are shown in table 8-22. In 
stage I there were 87 resected lung carcinomas. One patient had mors in tabulo and 
was therefore excluded from the final statistical analysis of the survival rate. In stage 
Survival 
rate 
Stage 1 
200 
M, 
400 600 800 1000 1200 1400 1600 " 1800 
days after resection 
Table 8-22 Survival curves according to stage-classification after resection, expressed in days. 
Ml, M2en M3 arc median survival 
Survival according to Kaplan Meier including early mortality and death from lung cancer, excluding mors 
in tabulo and loss of follow up. 
- # stage I 
- O stage II 
• stage III 
n - 8 6 
n = 34 
η = 35 
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II there were 35 resected lung carcinomas. In one patient there were no data available 
about survival; this patient also was excluded from the final statistical analysis of the 
survival rate. In stage III there were 37 patients. Two patients had mors in tabulo 
and therefore were excluded from the final statistical analysis of the survival rate. 
VIII.3.3.4 Survival curves of resected and mresected patients with lung carcinomas with 
N2 status. 
The median survival of patients with unresected lung carcinomas with N2 status 
(established at cervical and/or parasternal mediastinoscopy) is 225 days (0,6 year). 
The median survival of patients with resected lung carcinomas with N2 status is also 
225 days. Of the 19 resected patients with N2 status lung carcinoma, 14 died within 
a year, 9 of them within 3 months. Of the remaining 5 patients, 3 died in the second 
year, after 403, 404 and 523 days, and 2 are still alive after 306 and 544 days. These 
2 patients had pneumonectomy of the left lung after negative cervical mediastinoscopy. 
The survival curves, expressed in terms of days, are presented in table 8-23. There 
were 19 patients in the group of resected N2 status lung carcinomas. All are included 
in the final statistical analysis of the survival rate. There were 54 patients with N2 
Table 8-23 Survival curves of resected and unresected patients with Ντ status lung carcinoma. 
M indicates median survival. Survival according to Kaplan Meier 
Survival. 
rate 
N2 status resected, n = 19 
N2 status not resected, delected 
at cervical or parasternal 
mediastinoscopy, η = 47 
200 M 400 600 
• survival m days 
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status established at mediastinoscopy. In the early period two of these patients had, 
despite mediastinoscopically established N2 status, thoracotomy but no resection of 
the lung carcinoma was possible. They were enlisted in the twenty-five explorative 
thoracotomies. In five patients there were no data available about survival, so they 
were excluded from the final statistical analysis of the survival rate. 
No significant difference in the survival rates of both groups could be demonstrated, 
according to the logrank test (p = 0.54). 
VIII.3.3.5 Survival of patients who had only explorative thoracotomy. 
The median survival in the group of patients with incurable lung carcinomas, in 
whom only explorative thoracotomy was performed, is 250 days (0,7 year). 
The survival curve, expressed in terms of days, is presented in tabic 8-24. There 
were 25 patients who had non-curative or irresectable lung carcinoma at thoracotomy. 
In one patient there were no data available about survival, so this patient was excluded 
from the final statistical analysis of the survival rate. 
VIII.4 Summary. 
The yield of lymph node metastases at cervical mediastinoscopy is substantially 
lower in lung carcinomas spreading from the left upper lobe than in those spreading 
from the right lung or the left lower lobe. This is confirmed in the literature. The 
Tabic 8-24. Survival in explorative thoracotomy, expressed in days, η = 24. 
M indicates median survival Survival according to Kaplan Meier. 
Survival 
rate 
1 Ο ­
ι 
I 
I 
0 5 -
oi ; 
0 200 M 400 600 800 
days after explorative thoracotomy 
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cause of this is that the pen-aortic lymph nodes, which constitute an important link 
in the chain of lymphatic drainage of the left upper lobe, are not accessible at cervical 
mediastinoscopy. These pen-aortic nodes can be reached, however, via the parasternal 
approach of mediastinoscopy Combining cervical and parasternal mediastinoscopy 
in lung carcinomas spreading from the left upper lobe, will raise the percentage of 
lymph node metastases found in left-lung carcinomas to that in right-lung carcinomas 
This applies especially to carcinomas spreading from the left upper lobe at parasternal 
mediastinoscopy after negative cervical mediastinoscopy, only one case of lung carci­
noma spreading from the left lower lobe (in group II) was found to have pen-aortic 
lymph node metastasis. 
No serious complications occurred after parasternal mediastinoscopy The tech­
nique of parasternal mediastinoscopy will not present the experienced thoracic surgeon 
with any difficulties The early mortality in stage I and stage II lung carcinomas is 
equal· 5,7%. The early mortality in stage III carcinomas is 24,3%, including the T3N0 
combination with 11,1% early mortality There is a tendency to statistical significance 
in the differences in survival between resected T3N0 and T3N2 combinations accord­
ing to the logrank test (p = 0,08). 
The survival of stage-Ill carcinomas is significantly shorter than that of stage-II 
carcinomas, which in turn is significantly shorter than that of stage-1 carcinomas The 
median survival in stage I lung carcinomas is 4,3 years, in stage II lung carcinomas 
1,2 years and in stage III lung carcinomas 0,6 year 
No significant difference could be demonstrated between the survival of resected 
patients with N2 status lung carcinoma and that of patients with lung carcinoma with 
N2 status (established at mediastinoscopy) who did not have thoracotomy The medi­
an survival is 225 days, 0,6 year, in both groups Surgical salvage is negative in the 
group of lung carcinomas with N2 status. 
If cervical and parasternal mediastinoscopy are performed in the pre- operative ex­
amination of peripheral T2 carcinomas and all central carcinomas spreading from 
the left upper lobe, unnecessary thoracotomy would be avoided m cases where medias­
tinal lymph node metastasis has been demonstrated 
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CHAPTER IX 
GENERAL SUMMARY AND CONCLUSIONS 
A retrospective study of literature and our own material shows that at cervical me-
diastinoscopy about half as many mediastinal lymph node metastases are identified 
in carcinomas spreading from the left upper lobe as in carcinomas spreading from 
the right lung or the left lower lobe The literature confirms that at cervical mediastin-
oscopy the yield of mediastinal lymph node metastases is lower in left upper lobe 
lung carcinomas This is caused by the fact that the left upper lobe does not drain 
lymph via the bifurcation and paratrachcal lymph node chains, as the left lower lobe 
and the right lung do, but via the left anterior mediastinal lymph node chain, which 
includes the pen-aortic lymph nodes Rouvière was the first to describe the lymphatic 
drainage pathway of the left lung along this pen-aortic lymph node chain. Cordier 
examined which lung segments drain to this lymph node chain These segments are: 
the apical, dorsal and ventral segments of the left upper lobe, and the cranial and 
caudal segments of the lingula. It should be remarked once more that this pen-aortic 
lymph node chain is not accessible at cervical mediastinoscopy. These lymph nodes 
can be reached, however, via left parasternal mediastinoscopy, and biopsies can be 
taken from them for histological examination. The technique of parasternal mediastin-
oscopy and any possible complications are discussed The number of mediastinal 
lymph node metastases identified at combined cervical and parasternal mediastinos-
copy performed in carcinomas spreading from the left upper lobe, is proportionately 
equal to that identified at cervical mediastinoscopy alone, as it is performed in right-
lung carcinomas This is shown by the results of a prospective study and confirmed 
by the results of studies involving parasternal mediastinal exploration 
The surgical treatment of stage-Ill lung carcinomas is still controversial, in particu-
lar the treatment of stage-Ill lung carcinomas whose stage- classification is determined 
by lymphatic metastasis to the mediastinum. These are referred to as N2 status carcino-
mas To make it possible to compare different scries involving N2 status lung carcino-
mas which have been surgically treated, the TNM-system has been introduced In 
accordance with the idea that 'rescctabihty is a state of mind', selectivity is the basis 
for the pre-operative evaluation of the opcrabihty of lung carcinomas with N2 status. 
After all, the point is to perform thoracotomy and resection in those patients who 
are amenable to potentially curative resection. The development of cervical mediastin-
oscopy has raised considerably the resectabihty rate, the assumption being that once 
mediastinal lymph node metastasis has been identified, curative resection has become 
impossible and the prognosis extremely poor, whether or not resection is performed. 
To examine the validity of this assumption, all published patient series were collected 
that involved resection for lung carcinoma with N2 status. In the evaluation of the 
surgical treatment of lung carcinoma with N2 status, the following points have been 
considered 
1 The percentage of explorative thoracotomies and the percentage of related operative 
74 
mortality. 
2 The survival after resection for N2 status lung carcinoma, with special attention 
given to histology of the tumour and intranodal or perinodal growth of lymph node 
metastasis. 
3 The percentage of operative mortality related to resection for N2 status lung carci-
noma. 
The definition of surgical salvage ( = % 5-year survival - % operative mortality 
at resection - % operative mortality at only explorative thoracotomy) according to 
Paulson (1971) was used to make it possible to compare the separate series of the 
various authors. 
During the last 20 years, the operative mortality, in the literature, from explorative 
thoracotomy has remained remarkably constant: about 5%. Before the introduction 
of cervical mediastinoscopy, the number of explorative thoracotomies in the literature 
made up about 40% of the total number of thoracotomies in patients with lung carcino-
ma. As a result of the introduction of cervical mediastinoscopy into the pre-operative 
evaluation of the operability of lung carcinomas that could in principle be considered 
amenable to potentially curative resection, the resectability rate, in the literature, in-
creased considerably and the number of explorati ve thoracotomies dropped considera-
bly, now varying from 1.7% to 23.9%. Improved selection in the pre-operative evalua-
tion of the operability seems to be the basis for the increase in the resectability rate. 
To assess the value of this improved selection by means of cervical mediastinoscopy, 
the results of surgical treatment for lung carcinoma with N2 status are of great impor-
tance. These results have been gathered from the literature and fall into 2 main groups. 
One group involves resected patients with lung carcinoma in whom the N2 status 
was not established until at thoracotomy, whether or not preceded by negative cervical 
mediastinoscopy. Negative cervical mediastinoscopy means that at cervical mediastin-
oscopy no lymph node metastasis in the mediastinum was identified. The other group 
involves resected patients in whom the N2 status was already established at mediastin-
oscopy. In both groups the average surgical salvage is negative. This means that the 
percentage of operative mortality is higher than the percentage of survival. Great care 
should therefore be taken in the definition of indications for surgical treatment of 
lung carcinoma with N2 status. 
A third group comprises resected patients with N2 status lung carcinoma, who were 
selected because in them lymph node metastasis was intranodal and its location ipsila-
teral, preferably tracheobronchial, and in whom the nature of the N2 status was estab-
lished at thoracotomy or after cervical mediastinoscopy. In this group of patients with 
N2 status carcinoma, surgical salvage is positive. This means that this carefully selected 
group of patients with N2 status carcinoma benefits from surgical treatment. This 
applies especially to patients with squamous cell carcinoma with N2 status. It is unclear 
if this also applies to patients with adenocarcinoma with N2 status. The data of Nar-
uke, Kirschner and Martini seem to suggest that resection is beneficial. 
The two main groups that were mentioned above and that were not selected accord-
ing to intranodal or perinodal growth of Jymph node metastasis, also show a percent-
age of survival. Possibly this survival is to be found in the group of patients with 
N2 status carcinoma where the growth of lymph node metastasis is intranodal. Indeed, 
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in the group where N2 status lung carcinomas with intranodal lymph node metastasis 
were separated from those with pennodal lymph node metastasis, there is virtually 
no survival in the patients with pennodal lymph node metastasis Stricter pre-operative 
selection of N2 lung carcinomas with intranodal, ipsilaleral lymph node metastasis 
offers a chance of cure and consequently this carefully selected group of N2 status 
carcinomas should be advised to undergo resection In this group resection may be 
expected to be curative From this it may be concluded that cervical mediastinoscopy 
is a suitable technique for selecting patients with N2 status carcinoma with intranodal 
lymph node metastasis in the pre-operative evaluation of the operabihty It is essential, 
however, that the biopsies taken at cervical and parasternal mediastinoscopy are good 
enough for the pathologist to determine intranodal and/or pennodal growth Biopsies 
should include lymph node capsules and surrounding fatty tissue and their exact loca-
tion should be recorded as in figure 4-1 Selectivity is the basis of the evaluation of 
the operabihty of patients with N2 lung carcinoma, for indeed, the patient does not 
benefit from non-curative resection and only-explorative thoracotomy On the contr-
ary, life-expectancy is very poor, then Surgery remains the therapy of choice in cases 
where cure may be expected 
On the basis of data from the literature and a retrospective study in the Camsius-
Wilhelmina Hospital, Nijmegen, a prospective study was made of the value of paraster-
nal mediastinoscopy in carcinomas spreading from the left lung in the Camsius-Wilhel-
mma Hospital, Nijmegen, and in carcinomas spreading from the left upper lobe in 
the Lung Centre of the Radboud University Hospital, Nijmegen, and Dekkerswald 
Medical Centre, Grocsbeck In each case parasternal mediastinoscopy was performed 
after negative cervical mediastinoscopy. Combined cervical and parasternal medias-
tinoscopy raises the percentage of mediastinal lymph node metastases identified in 
left upper lobe carcinomas, proportionately, to the percentage of mediastinal lymph 
node metastases identified in right-lung carcinomas at cervical mediastinoscopy alone. 
This indicates that parasternal mediastinoscopy is a valuable supplement to cervical 
mediastinoscopy in the pre-operative evaluation of the operabihty in lung carcinomas 
spreading from the left upper lobe Parasternal mediastinoscopy has not been demon-
strated to have the same effect in lung carcinomas spreading from the left lower lobe 
There are significant differences between the survival rates in each of the separate 
stage-groups I, II and III (according to the TNM-system) There is no significant differ-
ence in the survival rates of patient groups with N2 status carcinoma which were re-
sected after negative cervical and/or parasternal mediastinoscopy and those who were 
not resected after the N2 status had been established at mediastinoscopy Nearly all 
patients with resected N2 status carcinoma had already pennodal lymph node metasta-
sis The median survival in this group is 225 days, which is the same as in the group 
of unresected N2 status patients. The retrospective study group comprised 131 left 
and right-lung carcinomas, the prospective study group comprised 111 left-lung carci-
nomas, 70 of them upper lobe carcinomas 
The conclusions that can be drawn from our own studies and the review of the 
literature are 
- Establishing intranodal or pennodal growth of lymph node metastasis is of great 
clinical importance in the pre-opera live evaluation of the operabihty oflung carcino-
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ma with N2 status Accordingly, during cervical or parasternal mediastinoscopy, 
biopsies should be taken containing lymph node tissue with surrounding mediastinal 
fatty tissue and the capsule. 
- Selectivity is the basis of the evaluation of the operability of lung carcinoma with 
N2 status 
- In the evaluation of the operability of carcinomas spreading from the left upper 
lobe, cervical mediastinoscopy alone is inadequate. 
- Combined cervical and parasternal mediastinoscopy is an effective method of deter-
mining mediastinal lymphatic metastasis in lung carcinomas spreading from the 
left upper lobe. 
- Parasternal mediastinoscopy performed after negative cervical mediastinoscopy 
does not provide much more information on lymphatic metastasis in carcinomas 
spreading from the left lower lobe than cervical mediastinoscopy does. 
- After negative cervical mediastinoscopy, parasternal mediastinoscopy should be 
performed as a routine procedure in patients with lung carcinoma spreading from 
the left upper lobe who are considered amenable to curative resection. 
- The histologic information on the status of the mediastinal lymph nodes and on 
the intranodal or perinodal growth of lymph node metastasis, as obtained at medias-
tinoscopy, is superior to information obtained through other, non-invasive tech-
niques. 
- Serious complications after biopsy at mediastinoscopy do not often occur, and if 
they do, they are of small significance in comparison with the information obtained. 
- The histologic information obtained is of considerable practical importance in deter-
mining which procedure is to be followed in treating the patient and in evaluating 
the prognosis of the procedure Both cervical and parasternal mediastinoscopy con-
tribute to a careful selection of suitable candidates for potentially curative surgical 
treatment 
- Unnecessary explorative thoracotomy and related morbidity and mortality will be 
avoided if parasternal mediastinoscopy is performed in the pre-operative evaluation 
of the operability in left upper lobe lung carcinomas. 
- Patients with intranodal, ipsilateral, tracheobronchial N2 status established at cervi-
cal mediastinoscopy, arc entitled to a thoracotomy, in the case of not unfavourable 
histology. With respect to parasternal mediastinoscopy, this has to be proved yet 
- Assuming the intrapulmonary lymph nodes situated along the left pulmonary artery 
are the origin of the left anterior mediastinal lymph node chain, it may well be 
that limited intranodal metastasis of the pen- aortic lymph nodes (the first station 
of this chain) does not necessarily rule out the possibility of a potentially curative 
resection Careful selection and prospective studies will demonstrate whether this 
hypothesis is valid 
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CHAPTER Χ 
SAMENVATTING EN CONCLUSIES 
Retrospectief onderzoek in literatuur en eigen materiaal toont aan dat bij cervicale 
mediastinoscopie de opbrengst aan mediastmale lymfeklieruitzaaiingen bij longcarci­
nomen uitgaande van de linker bovenkwab ongeveer de helft lager is dan de opbrengst 
welke verkregen wordt bij cervicale mediastinoscopie bij longcarcinomen uitgaande 
van de rechter long of Imker onderkwab. De literatuur bevestigt voor de linker boven­
kwab bij cervicale mediastinoscopie deze lagere opbrengst aan mediastmale lymfeklier 
uitzaaiingen De oorzaak hiervan is gelegen in het feit dat de linker bovenkwab niet 
hoofdzakelijk draineert langs de bifurcatie en paratracheale lymfekherketens, zoals 
de linker onderkwab en rechter long, maar via de linker peri-aortale lymfekherketen, 
waaronder de peri-aortale lymfeklieren Rouvière beschreef als eerste de lymfedraina-
ge van de linker long langs deze peri-aortale lymfekherketen aan Cordier onderzocht 
welke longsegmenten naar deze lymfeklieren draineren Deze segmenten zijn het apica-
le, dorsale en ventrale segment van de linker bovenkwab en het craniale en caudale 
segment van de lingula Nogmaals zij opgemerkt dat deze peri-aortale lymfekherketen 
niet bij de cervicale mediastinoscopie bereikbaar is. Door toepassing van parasternale 
mediastinoscopie zijn de peri-aortale lymfeklieren wel bereikbaar en na biopsie voor 
histologisch onderzoek bruikbaar De techniek van de parasternale mediastinoscopie, 
evenals de mogelijke complicaties, worden besproken 
De opbrengst aan mediastmale lymfeklieruitzaaiingen bij gecombineerde cervicale 
en parasternale mediastinoscopie bij longcarcinomen uitgaande van de linker boven-
kwab is relatief gelijk geworden aan de resultaten van de cervicale mediastinoscopie, 
zoals verricht wordt bij rechter longcarcinomen Dit blijkt uit prospectief onderzoek 
en wordt in de literatuur over parasternale mediastinum exploratie bevestigd 
Over de chirurgische behandeling van stadium Ш longcarcinomen bestaat nog 
steeds controverse Dit geldt met name voor stadium III longcarcinomen, waarbij het 
stadium bepaald wordt door de lymfogene uitzaaiing naar het mediastinum Deze 
zijn steeds als N2 status aangeduid Mede om vergelijking tussen de afzonderlijke se­
ries, waarbij de N2 status longcarcinomen chirurgisch zijn behandeld mogelijk te ma­
ken, is het TNM systeem ingevoerd Vanuit het denkbeeld dat operabiliteit niet hetzelf­
de is als resectabiliteit ligt selectiviteit ten grondslag aan de preopcratieve beoordeling 
van de operabiliteit bij longcarcinomen met N2 status Immers het gaat er alleen om 
die patiënten thoracotomie en resectie te laten ondergaan bij wie een in opzet curatieve 
resectie verwacht mag worden De ontwikkeling van de cervicale mediastinoscopie 
heeft de resectabiliteitsgraad aanzienlijk doen toenemen, waarbij ervan uitgegaan 
wordt dat, wanneer er metastasen in de mediastmale lymfeklieren aanwezig zijn een 
curatieve resectie onmogelijk geworden is en daarmee de prognose quod vitam uiterst 
somber Teneinde deze laatste veronderstelling te toetsen zijn alle gepubliceerde paticn-
tensenes verzameld, waarbij resecties van longcarcinomen met N2 status verricht zijn 
In de beoordeling van de chirurgische behandeling van longcarcinomen met N2 status 
zijn de volgende overwegingen in acht genomen 
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1 het percentage exploratieve thoracotomieen en het daaraan gerelateerde percentage 
operatie-mortahteil, 
2 de 5-jaars overleving na resectie in geval van N2 status longcarcinomen, waarbij 
gelet werd op de histologie van de primaire tumor en op intranodale en pennodale 
groeiwijze van lymfekliermetastasen, 
3 het percentage operatie-mortahteit dat gekoppeld is aan de resectie resultaten in 
geval van resectie van N2 status longcarcinomen 
De definitie van surgical salvage ( = percentage 5-jaars overleving - percentage ope-
ratie-mortahteit na resectie- percentage operatie-mortahteit na exploratieve thoraco-
tomie) volgens Paulson, 1976, werd toegepast om de afzonderlijke series van de diverse 
auteurs enigszins te kunnen vergelijken 
Gedurende de afgelopen 20 jaar is, in de literatuur, de operatie-mortahteit in geval 
van exploratieve thoracotomie opmerkelijk constant gebleven en schommelt rond de 
5%. Vóór de invoering van de cervicale mediastinoscopie bedraagt het aantal explora-
tieve thoracotomieen in de literatuur + 40% van het totaal aantal thoracotomieen 
bij patiënten met longcarcinomen Ten gevolge van de invoering van de cervicale me-
diastinoscopie in de preoperatieve beoordeling van de operabiliteit van longcarcino-
men, dat wil zeggen waar nog een in opzet curatieve resectie verwacht mag worden, 
is de resectabihteitsgraad aanzienlijk gestegen en het aantal exploratieve thoracoto-
mieen drastisch gedaald, nog variërend tussen de 1,7% en 23,9%. Toegenomen selectie 
in de preoperatieve operabiliteitsbeoordeling lijkt aldus aan de basis te liggen van de 
toegenomen rcsectabiliteitsgraad 
Teneinde de waarde van deze toegenomen selectie via cervicale mediastinoscopie 
te beoordelen zijn de resultaten van de chirurgische behandeling van longcarcinomen 
met N2 status van groot belang Deze zijn uit de literatuur verzameld en vallen in 
twee hoofdgroepen uiteen De eerste groep omvat patiënten met longcarcinomen die 
resectie ondergingen waarbij de N2 status pas tijdens thoracotomie kwam vast te staan, 
al dan niet na voorafgaande negatieve cervicale mediastinoscopie. (Negatieve cervicale 
mediastinoscopie betekent dat tijdens cervicale mediastinoscopie geen lymfekheruit-
zaanngen in het mediastinum zijn aangetoond.) De tweede groep waarbij resectie 
plaatsvond nadat de N2 status reeds bij mediastinoscopie was vastgesteld Voor beide 
groepen geldt dal de gemiddelde surgical salvage negatief is Dit wil zeggen dat het 
percentage operatie mortaliteit het percentage overleving overtreft. Dit houdt in dat 
grote zorgvuldigheid geboden is bij de indicatiestelling tot chirurgische behandeling 
van longcarcinomen met aangetoonde N2 status 
Een derde groep bestaat uit patiënten met longcarcinomen met N2 status die resectie 
ondergingen, waarbij de N2 status nader uitgeselecteerd is naar intranodale groei wijze 
binnen de lymfekhermetastase en ipsilateraal, bij voorkeur tracheobronchiaal voorko-
men van de lymfekhermetastase, waarbij de aard van de N2 status werd vastgesteld 
tijdens thoracotomie of na cervicale mediastinoscopie. Voor deze laatste groep patiën-
ten met N2 status longcarcinoom is de surgical salvage positief. Dit betekent dat deze 
hoog uitgeselecteerde groep patiënten met N2 status duidelijk baat heeft bij chirurgi-
sche behandeling Dit geldt met name voor patiënten met plaveiselcelcarcinomen met 
N2 status. Of dit ook geldt voor patiënten met adenocarcinomen met N2 status is 
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nog onduidelijk De gegevens van Naruke, Kirschner en Martini wijzen in de richting 
van baat in geval van resectie 
De twee eerstgenoemde hoofdgroepen, niet uitgeselecteerd naar intra- of perinodale 
groeiwijzc van de lymfekliermetastasen tonen ook een percentage overleving. Het valt 
te verwachten dat deze overleving voornamelijk in de N2 status met intranodalc 
grociwijze van de lymfekliermetastasen gelegen is. Immers daar waar de N2 status 
met pennodale groeiwij/c binnen de lymfekliermetastasen uitgeselecteerd werd, is de 
5-jaarsoverlcving steeds vrijwel 0 Dit betekent dat toegenomen preoperatieve selectie 
bij longcarcinomen met N2 status, waarbij de N2 status beperkt blijft tot intranodaal 
ipsilatcraal voorkomen een kans op curatie biedt en dus deze hoog uitgeselecteerde 
groep met N2 status thoracotomie geadviseerd moet worden. Voor de/e groep bestaat 
de verwachting van een in opzet curatieve resectie Hieruit kan geconcludeerd worden 
dat de cervicale mediastinoscopie een goede techniek is om patiënten in de preoperatie-
ve beoordeling van de operabiliteit in geval van N2 status uit te selecteren voor mo-
gelijke resectie, namelijk alleen dan wanneer de lymfekliermetastase in grociwijze be-
perkt blijft tot intranodaal Voorwaarde hiertoe zijn zodanige biopten bij cervicale 
en parastcrnale mediastinoscopie dat de patholoog-anatoom onderscheid in intra- en/ 
of pennodale grociwijze kan maken Biopten moeten lymfekherkapsel en omgevend 
vetweefsel bevatten I lun precíese afnameplaats moet worden weergegeven /oals aan-
gegeven in figuur 4-1 Selectiviteit ligt aan de basis van de beoordeling van de operabili-
teit van longcarcinomen met N2 status. Immers bij met-curatieve resectie en explora-
tieve thoracotomie heeft de patient geen baat, integendeel de levensverwachting is dan 
uiterst somber 
Chirurgische behandeling blijft wanneer curatie verwacht mag worden, dé therapie. 
Op grond van de literatuurgegevens en retrospectief onderzoek in het Camsius-Wil-
helmina Ziekenhuis te Nijmegen, werd prospectief onderzoek verricht naar de waarde 
van de parastcrnale mediastinoscopie bij longcarcinomen uitgaande van de linker long 
in het Camsius-Wilhelmina Ziekenhuis te Nijmegen en bij longcarcinomen uitgaande 
van de linker bovenkwab in het St Radboudziekenhuis te Nijmegen en in het Medisch 
Centrum Dekkerswald te Grocsbeek Steeds werd parastcrnale mediastinoscopie ver-
richt na voorafgaande negatieve cervicale mediastinoscopie Door de gecombineerde 
cervicale en parastcrnale mediastinoscopie blijkt het percentage mediastinale lymfe-
kliermetastasen dat bij linker bovenkwabtumoren aangetroffen wordt, proportioneel, 
gelijk te worden aan het percentage mediastinale lymfekliermetastasen dat aangetrof-
fen wordt bij rechter longcarcinomen, waarbij alleen cervicale mediastinoscopie wordt 
verricht Dit betekent dal de parastcrnale mediastinoscopie een waardevolle aanvul-
ling is op de cervicale mediastinoscopie in de preoperatieve beoordeling van de opera-
biliteit bij longcarcinomen uitgaande van de linker bovenkwab Voor carcinomen uit-
gaande van de linker onderkwab is dit effect voor de parastcrnale mediastinoscopie 
niet aangetoond 
Tussen de afzonderlijke stadiumgroepen I, II en III (volgens het TNM systeem) 
bestaat een significant verschil in overleving na resectie Geen significant verschil in 
overleving kan worden aangetoond tussen patiëntengroepen met N2 status welke re-
sectie ondergingen al dan niet na voorafgaande negatieve cervicale en/of parastcrnale 
mediastinoscopie en die geen resectie ondergingen na mediastmoscopisch vastgestelde 
N2 status BIJ vrijwel alle gereseceerdc N2 status bestond reeds een pennodale lymfe-
80 
kliermetastasermg De mediane overleving in deze groep bedraagt 225 dagen, gelijk 
aan de mediane overleving bij de niet gcrcseceerde N2 status. De retrospectieve onder-
zoeksgroep omvat 131 linker en rechter longcarcinomen, de prospectieve onderzoeks-
groep omvat 111 linker longcarcinomen, waarvan 70 uitgaande van de linker boven-
kwab. 
De conclusies die op grond van eigen onderzoek en literatuurstudie getrokken wor-
den /ijn. 
- Het vaststellen van intranodale of perinodale groeiwijze van de lymfekhermetasta-
sen in het mediastinum is van grote klinische betekenis in de preoperatieve beoorde-
ling van de operabiliteit bij longcarcinomen met N2 status. De wijze van biopleren 
tijdens cervicale of parasternale mediastinoscopie dient daarop gericht te zijn, te 
weten, lymfeklierweefsel mét omgevend mediastinaalvetwecfscl én kapsel 
- Selectiviteit ligt aan de basis van de operabiliteitsbepalmg van longcarcinomen met 
N2 status. 
- Bij longcarcinomen uitgaande van de linker bovenkwab is de cervicale mediastino-
scopie alleen, ontoereikend in de beoordeling van de operabiliteit 
- Gecombineerde cervicale en parasternale mediastinoscopie is een goede methode 
om de mediastinale lymfeklieruitzaaiingen bij longcarcinomen uitgaande van de lin-
ker bovenkwab vast te stellen 
- Parasternale mediastinoscopie uitgevoerd na negatieve cervicale mediastinoscopie 
biedt vrijwel geen extra informatie over mediastinale lymfckheruit/aaiing bij long-
carcinomen uitgaande van de linker onderkwab 
- Na negatieve cervicale mediastinoscopie dient parasternale mediastinoscopie routi-
nematig uitgevoerd te worden bij patiënten met longcarcinomen uitgaande van de 
linker bovenkwab waarbij een in op/ct curatieve resectie mogelijk verondersteld 
wordt. 
- De histologische informatie die bij mediastinoscopie verkregen wordt over de status 
van de mediastinale lymfeklieren en daarenboven over de intranodale of perinodale 
groeiwijze binnen de lymfeklier wanneer het uitzaaiingen betreft is superieur aan 
andere, niet-mvasieve technieken 
- Het vóórkomen van ernstige complicaties na biopsie bij mediastinoscopie is gering 
en daarnaast onbeduidend vergeleken met de informatie die verkregen wordt 
- De verkregen histologische informatie na mediastinoscopie is van grote praktische 
betekenis voor het op te stellen beleidsplan van behandeling en voor een beoordeling 
van de prognose hiervan bij patiënten met longcarcinomen Zowel cervicale als pa-
rasternale mediastinoscopie dragen zorg voor een zorgvuldige selectie van geschikte 
kandidaten voor een in opzet curatieve chirurgische behandeling. 
- Onnodige exploratieve thoracotomie met daarbij behorende morbiditeit en mortali-
teit worden door toepassing van de parasternale mediastinoscopie voorkomen 
- Patiënten met een ccrvicaal mcdiastinoscopisch vastgestelde intranodale ipsilateralc 
tracheobronchiale N2 status dient een thoracotomie geadviseerd te worden, bi| niet 
ongunstig histologisch celtype. Ten aanzien van de parasternale mediastinoscopie 
moet dit nog aangetoond worden 
- Wanneer de intrapulmonale lymfeklieren gelegen langs de arteria pulmonalis sinis-
tra als oorsprong van de linker pen-aortale lymfeklierketen beschouwd mogen wor-
den, kan de verwachting bestaan dat de pen-aortale lymfeklieren als eerste station 
81 
van deze keten, in geval van lymfeklieruitzaaimg met slechts intranodale groei, een 
in opzet curatieve resectie niet uitsluiten Zorgvuldige selectie en prospectief onder-
zoek zullen dit moeten uitwijzen 
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ADDENDA 
Addendum 1 AH 184 patients underwent rcscctional or non-resectional surgery in study group I, II and 
III 
Operation II 
N 
4 
14 
7 
0/ 
0 
13.3 
46,7 
23,3 
III 
N 
2 
26 
7 
О 
3,6 
47,3 
12,7 
Explorative thoracotomy 
Lobectomy L U L.* 
L L L 
RU.L. 
RL.L. 
19 
14 
5 
9 
2 
19,2 
14,1 
5,1 
9,1 
2,0 
Bilobectomy R U 'M L. 
R M iL.L. 
2,0 
5,1 
Pneumonectomy Left 
Right 
14 
29 
99 
14,1 
29,3 
30 
16,7 20 
55 
36.4 
I..U L = Left Upper Lobe 
L L.L. = Left Lower Lobe 
R U L . = Right Upper Lobe 
R L L = Right Lower Lobe 
R U /M L = Right Upper/Middle Lobe 
R.M /L L. = Right Middle/Lower Lobe 
Addendum 2. Survival in days after resection of N2 status lung carcinomas, correlated to histology, type 
of resection and performed mediastinoscopy 
Τ status 
TI 
Tl 
Tl 
Tl 
T2 
T2 
Τ2 
Τ2 
Τ2 
Τ2 
Τ2 
Τ2 
Τ3 
Γ3 
Τ3 
Τ3 
Τ3 
Τ3 
Τ3 
Histology 
adeno 
adeno 
small-cell 
small-cell 
squamous 
squamous 
squamous 
squamous 
squamous 
squamous 
small-cell 
small-cell 
squamous 
squamous 
squamous 
squamous 
squamous 
adeno 
small-cell 
Type of resection 
pneumonectomy L 
lobectomy L U L 
lobectomy L U L 
lobectomy L U L . 
lobectomy R U L 
lobectomy L U.L. 
pneumotectomy R 
pneumonectomy L 
pneumonectomy L 
pneunomectomy L 
pneumonectomy L 
lobectomy L.U.L. 
pneunomectomy R 
pneunomectomy L 
pneunomectomy L 
pneunomectomy L 
pneunomectomy L 
bilobect R U /M L. 
pneunomectomy L 
Mediastinoscopy 
not performed 
not performed 
not performed 
not performed 
negative 
negative 
negative 
negative 
negative 
positive 
negative 
positive 
negative 
negative 
negative 
negative 
not performed 
negative 
not performed 
Survival 
233 
287 
523 
403 
26 
338 
322 
102 
544 
4 
33 
77 
53 
195 
306 
73 
60 
10 
404 
+ * 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
1 
+ 
+ 
+ 
+ 
+ 
1 
+ 
+ 
+ 
+ 
+ = death because of tumour adeno 
1 = alive without known metastases small-cell 
squamous = squamous cell carcinoma 
adenocarcinoma 
small-cell carcinoma 
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Addendum 3. Survival in days after resection of ГЗ status lung carcinomas, correlated to N status, histology 
and reason of T3 status, according to AJC, 1983. 
N status 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
N1 
N1 
N1 
N1 
N1 
N1 
N1 
N1 
N1 
N2 
N2 
N2 
N2 
N2 
N2 
N2 
Histology 
squamous 
squamous 
squamous 
squamous 
squamous 
adeno 
adeno 
branch alv 
fibrohistio 
squamous 
squamous 
squamous 
squamous 
squamous 
squamous 
squamous 
squamous 
large-cell 
squamous 
squamous 
squamous 
squamous 
squamous 
adeno 
small-cell 
Survival 
8 
143 
19 
89 
480 
486 
438 
1535 
507 
60 
0 
0 
1349 
11 
204 
181 
309 
173 
53 
195 
306 
60 
73 
10 
404 
+ * 
+ 
1** 
+ 
+ 
+ 
1 
1 
+ 
+ 
+ 
+ 
1 
+ 
2*** 
+ 
+ 
1 
+ 
+ 
1 
+ 
+ 
+ 
+ 
Reason of T3 
< 2 cm from carina 
thoracic wall involvement 
thoracic wall involvement 
thoracic wall involvement 
thoracic wall involvement 
thoracic wall involvement 
thoracic wall involvement 
thoracic wall involvement 
thoracic wall involvement 
tumor in resection plane bronchus 
combination of factors 
combination of factors 
< 2 cm from carina 
combination of factors 
thoracic wall involvement 
thoracic wall involvement 
mediastinal invasion 
atelectasis 
combination of factors 
combination of factors 
combination of factors 
mediastinal invasion 
combination of factors 
< 2 cm from carina 
debulking operation 
squamous = squamous cell carcinoma 
adeno = adenocarcinoma 
bronch alv — bronchial alveolar carcinoma 
small-cell = small-cell carcinoma 
large-cell = large-cell carcinoma 
fibrohistio = malignant fibrohistiocytoma 
* + = death because of tumour 
** 1 = alive without known metastases 
***2 = alive with known metastases or local tumour recurrence 
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NAWOORD 
Bij het schrijven van de laatste regels van dit proefschrift wil ik iedereen bedanken 
die aan het tot stand komen ervan heeft meegewerkt, onder wie menigeen in het bijzon-
der; op de eerste plaats mijn ouders die in mijn jeugd de basis hiertoe hebben gelegd. 
Deze studie werd bewerkt op de afdeling algemene heelkunde van het Canisius-
Wilhelmina Ziekenhuis (hoofd Dr. H.J.M. Joostcn). Mijn collegae-assistenten namen 
het vele werk over in de uren dat ik afwezig was. 
Prof. Dr. L.K.. Lacquet (hoofd afdeling thorax- hart- vaatchirurgie, St. Radboud 
Ziekenhuis te Nijmegen en consulent thoraxchirurgie Medisch Centrum Dckkerswald 
te Groesbeek) en Prof. C.M. Jongerius (hoofd van het Universitair longcentrum van 
het St. Radboud Ziekenhuis te Nijmegen en van het Medisch Centrum Dekkerswald 
te Groesbeek) wil ik bedanken voor hun bereidheid mij een deel van hun patiënten-
bestand, verwerkt in hel prospectieve deel van deze studie, ter beschikking te stellen. 
Drs. M.Mravunac, patholoog-anatoom, reviseerde alle patholoog-anatomische 
preparaten; Marcel, al het werk is niet voor niets geweest. 
Rob Havlik vervaardigde de tekeningen. 
Elly van Eimcrcn-Derksen en Yolanda Visser waren steeds bereid om de lange reeks 
medische dossiers te lichten en aan te leveren. Hartelijk dank hiervoor. 
Drs. P. van Eiteren en Dhr. A. Dinkhuijsen droegen zorg voor de statistische bewer-
king. 
Dr. H.W.O. Deleu, algemeen chirurg en Dr. W. van den Berg, longarts, gaven zin-
volle kritiek op het manuscript. 
Drs. F. de Groot, taalkundige, en Drs. J. Ellul, anaesthesist, waren een grote steun 
bij het tot stand komen van de Engelse tekst; Frans, buitengewoon waardeer ik je 
inzet om ook het hele proefschrift te willen begrijpen. Zoals je je wellicht herinnert, 
hebben we ons wel eens afgevraagd wie het proefschrift zou verdedigen. 
Mar Stuut bleef steeds paraat om de telkens weer veranderende tekst te verwerken; 
de uren die ik je bij Jan weghaalde hebben we toch aardig ingevuld samen. 
Dhr. L. de Goey bleek een ware vriend door zijn niet aflatende steun in hand en 
spandiensten; Leo, menigmaal kon ik je tot diep in de nacht storen. Zonder jouw 
hulp was het in dit tijdsbestek niet gelukt. Bedankt. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd op 24 maart 1949 geboren te Sillard. Na 
het behalen van het eindexamen gymnasium В aan het Bisschoppelijk College Si. Josef 
te Sittard studeerde hij van 1969 tot 1972 tandheelkunde aan de Rijksuniversiteit te 
Utrecht. Nog voor het kandidaatsexamen tandheelkunde behaald werd, maakte hij 
in 1971 een aanvang met de studie medicijnen. Injanuari 1978 werd de medische studie 
met het artsexamen te Nijmegen afgesloten. Na enige maanden in de huisartsen­
praktijk bij Th. van der Putten te Blerick gewerkt te hebben, startte hij zijn klinische 
opleiding eind april 1978 in het Canisius Wilhelmina Ziekenhuis te Nijmegen op de 
interne afdeling (opleider Dr J.H.J. Enneking). Op 1 september 1979 begon hij met 
de opleiding algemene heelkunde in het Canisius-Wilhelmina Ziekenhuis te Nijmegen 
(opleider Dr H.J.M. Joosten) die werd afgesloten met zijn inschrijving als algemeen 
chirurg per 1 september 1985. Vanaf 1 december 1985 zal hij werkzaam zijn in het 
Sint Radboudzickenhuis te Nijmegen, afdeling thorax- hart- vaatchirurgie, in oplei­
ding tot cardiopulmonaal chirurg (opleider Prof.Dr L.K. Lacquet). 
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Stellingen, behorend bij het proefschrift 
Parasternal Mediastinoscopy 
J. H. J. Schreinemakers 
Nijmegen, 14 november 1985 

1 
Selectiviteit ligt aan de basis van de operabihteitsbepaling van non-small cell longcarci-
nomen met N2 status. 
2 
Onnodige exploratievc thoracotomie met daarbij behorende morbiditeit en mortali-
teit wordt door toepassing van de paras temale mediastinoscopie voorkomen 
3 
Gecombineerde cervicale- en parasternale mediastinoscopie is een goede methode om 
de mediastinale lympheklicruitzaaiingen bij longcarcinomen, uitgaande van de hnker-
bovenkwab vast te stellen 
4 
Het vaststellen van intranodale of perinodale groeiwijze van lymphekliermetastasen 
in het mediastinum, is van grote klinische betekenis in de preoperatieve beoordeling 
van de operabiliteit bij longcarcinomen met N2 status 
De vnj/e van biopteren tijdens cervicale- of parasternale mediastinoscopie dient daar-
op gericht te zijn, te weten lympheklierweefsel met omgevend mediastinaal vetwcefsel 
én kapsel 
5 
Patienten met een cervicaal mediastinoscopisch vastgestelde intranodale ipsilaterale 
tracheobronchiale N2 status, dient een thoracotomie geadviseerd te worden bij niet 
ongunstig celtype Ten aanzien van de parasternale mediastinoscopie moet dit nog 
aangetoond worden 
6 
Dunne naaldcytologie bij mammatumoren levert een belangrijke bijdrage in de diag-
nostiek hiervan 
7 
Het lijkt verantwoord in streng geselecteerde gevallen een Akiyama bypass uit te voe-
ren met eventuele bestraling van het in situ gelaten oesophaguscarcinoom (J Th Pluk-
kers, dissertatie 1985) 
8 
Gezien de bestaande verschillen in definitie van T,N en M verdient het aanbeveling 
bij de TNM classificatie van een bronchuscarcinoom, de naam van het jaartal van 
het gebruikte systeem te vermelden (E M Noordijk, dissertatie 1983) 
9 
Het is geen schande om als clmicus de weg naar de anatomische snijzaal terug te vinden 
Integendeel, de samenwerking tussen anatomen en clinici dient, /eker binnen de oplei-
dingspenode, gestimuleerd te worden 
10 
Patienten met het syndroom van Klinefelter hebben een groot risico borstkanker te 
krijgen (A. N van Geel, dissertatie 1983). 
11 
De voorstelling van zwarte, geteerde longen, in anti-rook campagne folders is mislei-
dend Beter zou hel zijn deze folders als medische voorlichting te verstrekken aan 
werkers in steenkoolgrocven 
12 
Een Agio is altijd de sigaar. 


